##ANALYSISTYPE=CLINCNV_GERMLINE_SINGLE
##gender of sample: M
##number of iterations: 1 , quality used at final iteration: 20
##was it outlier after clustering? FALSE
##fraction of outliers: 0.029
#chr	start	end	CN_change	loglikelihood	no_of_regions	length_KB	potential_AF	genes	qvalue	cn_polymorphisms_zarrei	cn_polymorphisms_demidov	dosage_sensitive_disease_genes	omim
chr1	957571	978847	3	6	2	  21.276	0.134	AGRN	0.00131	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	979479	979829	3	3	2	   0.350	0.146	AGRN	0.01722	yes			103320_[AGRN_Myasthenic_syndrome,congenital,8,with_pre-_and_postsynaptic_defects,615120]
chr1	1960540	1961211	3	10	2	   0.671	0.115	GABRD	0.00113			GABRD	137163_[GABRD_Epilepsy,generalized,with_febrile_seizures_plus,type_5,susceptibility_to,613060/Epilepsy,idiopathic_generalized,10,613060/Epilepsy,juvenile_myoclonic,susceptibility_to,613060]
chr1	6534501	6535208	3	4	2	   0.707	0.248	PLEKHG5	0.01909				611101_[PLEKHG5_Spinal_muscular_atrophy,distal,autosomal_recessive,4,611067/Charcot-Marie-Tooth_disease,recessive_intermediate_C,615376]
chr1	10405893	10407895	1	4	2	   2.002	0.045	KIF1B	0.00493				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10420977	10421111	3	5	1	   0.134	0.102	KIF1B	0.00292				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	10435303	10435441	1	6	1	   0.138	0.083	KIF1B	0.00088				605995_[KIF1B_Charcot-Marie-Tooth_disease,type_2A1,118210/Pheochromocytoma,171300/Neuroblastoma,susceptibility_to,1,256700]
chr1	11853954	11854156	3	10	1	   0.202	0.089	MTHFR	0.00007				607093_[MTHFR_Homocystinuria_due_to_MTHFR_deficiency,236250/Schizophrenia,susceptibility_to,181500/Vascular_disease,susceptibility_to/Neural_tube_defects,susceptibility_to,601634/Thromboembolism,susceptibility_to,188050]
chr1	11854776	11855415	1	3	2	   0.639	0.134	MTHFR	0.01223				607093_[MTHFR_Homocystinuria_due_to_MTHFR_deficiency,236250/Schizophrenia,susceptibility_to,181500/Vascular_disease,susceptibility_to/Neural_tube_defects,susceptibility_to,601634/Thromboembolism,susceptibility_to,188050]
chr1	12030717	12033064	3	5	2	   2.347	0.083	PLOD1	0.00290				153454_[PLOD1_Ehlers-Danlos_syndrome,kyphoscoliotic_type,1,225400]
chr1	12049212	12049410	3	5	1	   0.198	0.083	MFN2	0.00471				608507_[MFN2_Charcot-Marie-Tooth_disease,axonal,type_2A2A,609260/Hereditary_motor_and_sensory_neuropathy_VIA,601152/Charcot-Marie-Tooth_disease,axonal,type_2A2B,617087]
chr1	16378195	16378325	1	3	1	   0.130	0.115	CLCNKB	0.00803	yes		CLCNKB	602023_[CLCNKB_Bartter_syndrome,type_3,607364/Bartter_syndrome,type_4b,digenic,613090]
chr1	16382907	17313774	3	6	5	 930.867	0.102	CLCNKB,ATP13A2	0.00346	yes	yes	CLCNKB	602023_[CLCNKB_Bartter_syndrome,type_3,607364/Bartter_syndrome,type_4b,digenic,613090],176946_[EPHA2_Cataract_6,multiple_types,116600],610513_[ATP13A2_Kufor-Rakeb_syndrome,606693/Spastic_paraplegia_78,autosomal_recessive,617225]
chr1	17316176	17316508	1	2	2	   0.332	0.115	ATP13A2	0.02078				610513_[ATP13A2_Kufor-Rakeb_syndrome,606693/Spastic_paraplegia_78,autosomal_recessive,617225]
chr1	17326885	17327039	4	3	1	   0.154	0.217	ATP13A2	0.02150				610513_[ATP13A2_Kufor-Rakeb_syndrome,606693/Spastic_paraplegia_78,autosomal_recessive,617225]
chr1	22151187	22155582	1	5	4	   4.395	0.057	HSPG2,LDLRAD2	0.00397			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22169253	22173102	3	11	5	   3.849	0.127	HSPG2	0.01095			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22175376	22179335	3	8	7	   3.959	0.121	HSPG2	0.09913			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22183498	22183698	1	6	1	   0.200	0.102	HSPG2	0.00111			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22191326	22191576	3	4	1	   0.250	0.064	HSPG2	0.00556			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22201374	22201505	1	3	1	   0.131	0.153	HSPG2	0.00699			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22202112	22202250	3	5	1	   0.138	0.115	HSPG2	0.00290			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22204669	22204756	4	10	1	   0.087	0.197	HSPG2	0.00019			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22206846	22207062	1	3	1	   0.216	0.102	HSPG2	0.00896			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22213698	22214177	3	4	2	   0.479	0.223	HSPG2	0.00404			HSPG2	142461_[HSPG2_Schwartz-Jampel_syndrome,type_1,255800/Dyssegmental_dysplasia,Silverman-Handmaker_type,224410]
chr1	22979672	22986146	1	3	2	   6.474	0.115	C1QB	0.05891				120570_[C1QB_C1q_deficiency,613652]
chr1	26136164	26138380	3	15	3	   2.216	0.108	SELENON	0.00555				606210_[SELENON_Muscular_dystrophy,rigid_spine,1,602771/Myopathy,congenital,with_fiber-type_disproportion,255310]
chr1	26503971	26504100	3	5	1	   0.129	0.102	CNKSR1	0.00264				
chr1	26506934	26507397	1	2	2	   0.463	0.115	CNKSR1	0.01261				
chr1	27057633	27058105	3	6	1	   0.472	0.102	ARID1A	0.00108			ARID1A	603024_[ARID1A_Coffin-Siris_syndrome_2,614607]
chr1	27695591	27695978	3	3	1	   0.387	0.096	FCN3	0.00991				604973_[FCN3_Immunodeficiency_due_to_ficolin_3_deficiency,613860]
chr1	27699617	27700952	1	6	2	   1.335	0.121	FCN3	0.00833				604973_[FCN3_Immunodeficiency_due_to_ficolin_3_deficiency,613860]
chr1	33251953	33252058	3	3	1	   0.105	0.121	YARS	0.01208				603623_[YARS_Charcot-Marie-Tooth_disease,dominant_intermediate_C,608323]
chr1	43393266	43393489	1	4	1	   0.223	0.032	SLC2A1	0.00286			SLC2A1	138140_[SLC2A1_GLUT1_deficiency_syndrome_1,infantile_onset,severe,606777/GLUT1_deficiency_syndrome_2,childhood_onset,612126/Epilepsy,idiopathic_generalized,susceptibility_to,12,614847/Dystonia_9,601042/Stomatin-deficient_cryohydrocytosis_with_neurologic_defects,608885]
chr1	43408887	43409002	3	6	1	   0.115	0.083	SLC2A1	0.00108			SLC2A1	138140_[SLC2A1_GLUT1_deficiency_syndrome_1,infantile_onset,severe,606777/GLUT1_deficiency_syndrome_2,childhood_onset,612126/Epilepsy,idiopathic_generalized,susceptibility_to,12,614847/Dystonia_9,601042/Stomatin-deficient_cryohydrocytosis_with_neurologic_defects,608885]
chr1	44290393	44290574	1	5	1	   0.181	0.038	ST3GAL3	0.00231				606494_[ST3GAL3_Mental_retardation,autosomal_recessive_12,611090/Epileptic_encephalopathy,early_infantile,15,615006]
chr1	45287928	45289067	3	7	3	   1.139	0.153	PTCH2	0.02384				603673_[PTCH2_Medulloblastoma,somatic,155255/Basal_cell_carcinoma,somatic,605462/Basal_cell_nevus_syndrome,109400]
chr1	45295571	45296725	1	10	2	   1.154	0.134	PTCH2	0.00284				603673_[PTCH2_Medulloblastoma,somatic,155255/Basal_cell_carcinoma,somatic,605462/Basal_cell_nevus_syndrome,109400]
chr1	45341280	45341377	3	4	1	   0.097	0.134	EIF2B3	0.00365				606273_[EIF2B3_Leukoencephalopathy_with_vanishing_white_matter,603896]
chr1	45363017	45392421	1	9	2	  29.404	0.064	EIF2B3	0.00636				606273_[EIF2B3_Leukoencephalopathy_with_vanishing_white_matter,603896]
chr1	46654343	46655249	1	2	2	   0.906	0.057	POMGNT1	0.02796			POMGNT1	606822_[POMGNT1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,3,253280/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,3,613151/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,3,613157/Retinitis_pigmentosa_76,617123]
chr1	47770551	47770678	3	4	1	   0.127	0.038	STIL	0.00370				181590_[STIL_Microcephaly_7,primary,autosomal_recessive,612703]
chr1	55337013	55337296	3	4	1	   0.283	0.076	DHCR24	0.00324				606418_[DHCR24_Desmosterolosis,602398]
chr1	55352552	55465046	3	5	2	 112.494	0.121	DHCR24,BSND	0.00839			BSND	606418_[DHCR24_Desmosterolosis,602398],606412_[BSND_Bartter_syndrome,type_4a,602522/Sensorineural_deafness_with_mild_renal_dysfunction,602522]
chr1	63894394	63894807	1	6	2	   0.413	0.057	ALG6	0.00226				604566_[ALG6_Congenital_disorder_of_glycosylation,type_Ic,603147]
chr1	92948920	92949153	4	5	1	   0.233	0.159	GFI1	0.00129				600871_[GFI1_Neutropenia,severe_congenital_2,autosomal_dominant,613107/Neutropenia,nonimmune_chronic_idiopathic,of_adults,607847]
chr1	110737191	110737403	1	5	1	   0.212	0.076	SLC6A17	0.00245				610299_[SLC6A17_Mental_retardation,autosomal_recessive_48,616269]
chr1	115258661	115258808	3	3	1	   0.147	0.115	NRAS	0.00434				164790_[NRAS_RAS-associated_autoimmune_lymphoproliferative_syndrome_type_IV,somatic,614470/Noonan_syndrome_6,613224/Epidermal_nevus,somatic,162900/Thyroid_carcinoma,follicular,somatic,188470/Colorectal_cancer,somatic,114500/Melanocytic_nevus_syndrome,congenital,somatic,137550/Neurocutaneous_melanosis,somatic,249400/Schimmelpenning-Feuerstein-Mims_syndrome,somatic_mosaic,163200]
chr1	115575973	115576155	1	3	1	   0.182	0.115	TSHB	0.00404				188540_[TSHB_Hypothyroidism,congenital,nongoitrous_4,275100]
chr1	150772010	150772195	1	4	1	   0.185	0.134	CTSK	0.00729				601105_[CTSK_Pycnodysostosis,265800]
chr1	154543655	154544647	4	4	1	   0.992	0.331	CHRNB2	0.00693			CHRNB2	118507_[CHRNB2_Epilepsy,nocturnal_frontal_lobe,3,605375]
chr1	155262958	155263391	1	4	2	   0.433	0.089	PKLR	0.00550				609712_[PKLR_Pyruvate_kinase_deficiency,266200/Adenosine_triphosphate,elevated,of_erythrocytes,102900]
chr1	155737206	155741018	3	4	2	   3.812	0.070	GON4L	0.00319				
chr1	155753767	155753890	3	4	1	   0.123	0.032	GON4L	0.00350				
chr1	156027759	156085075	3	4	2	  57.316	0.108	LAMTOR2,LMNA	0.05103			LMNA	610389_[LAMTOR2_Immunodeficiency_due_to_defect_in_MAPBP-interacting_protein,610798],150330_[LMNA_Emery-Dreifuss_muscular_dystrophy_2,autosomal_dominant,181350/Cardiomyopathy,dilated,1A,115200/Lipodystrophy,familial_partial,type_2,151660/Emery-Dreifuss_muscular_dystrophy_3,autosomal_recessive,616516/Charcot-Marie-Tooth_disease,type_2B1,605588/Muscular_dystrophy,congenital,613205/Mandibuloacral_dysplasia,248370/Hutchinson-Gilford_progeria,176670/Restrictive_dermopathy,lethal,275210/Heart-hand_syndrome,Slovenian_type,610140/Malouf_syndrome,212112]
chr1	156104968	156105113	1	3	1	   0.145	0.102	LMNA	0.01065			LMNA	150330_[LMNA_Emery-Dreifuss_muscular_dystrophy_2,autosomal_dominant,181350/Cardiomyopathy,dilated,1A,115200/Lipodystrophy,familial_partial,type_2,151660/Emery-Dreifuss_muscular_dystrophy_3,autosomal_recessive,616516/Charcot-Marie-Tooth_disease,type_2B1,605588/Muscular_dystrophy,congenital,613205/Mandibuloacral_dysplasia,248370/Hutchinson-Gilford_progeria,176670/Restrictive_dermopathy,lethal,275210/Heart-hand_syndrome,Slovenian_type,610140/Malouf_syndrome,212112]
chr1	156834510	156834601	1	3	1	   0.091	0.102	NTRK1	0.00614				191315_[NTRK1_Insensitivity_to_pain,congenital,with_anhidrosis,256800/Medullary_thyroid_carcinoma,familial,155240]
chr1	161275888	161276264	3	4	2	   0.376	0.140	MPZ	0.00045			MPZ	159440_[MPZ_Charcot-Marie-Tooth_disease,type_1B,118200/Dejerine-Sottas_disease,145900/Hypomyelinating_neuropathy,congenital,2,618184/Charcot-Marie-Tooth_disease,type_2J,607736/Roussy-Levy_syndrome,180800/Charcot-Marie-Tooth_disease,type_2I,607677/Charcot-Marie-Tooth_disease,dominant_intermediate_D,607791]
chr1	173800663	173806194	1	6	3	   5.531	0.096	DARS2	0.01842		yes		610956_[DARS2_Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement_and_lactate_elevation,611105]
chr1	197091279	197091441	1	4	1	   0.162	0.140	ASPM	0.00373				605481_[ASPM_Microcephaly_5,primary,autosomal_recessive,608716]
chr1	197098307	197099196	3	4	2	   0.889	0.083	ASPM	0.00642				605481_[ASPM_Microcephaly_5,primary,autosomal_recessive,608716]
chr1	197113077	197115834	1	5	2	   2.757	0.299	ASPM	0.07380				605481_[ASPM_Microcephaly_5,primary,autosomal_recessive,608716]
chr1	198691535	198691615	1	3	1	   0.080	0.580	PTPRC	0.19769				151460_[PTPRC_Hepatitis_C_virus,susceptibility_to,609532/Severe_combined_immunodeficiency,T_cell-negative,B-cell/natural_killer-cell_positive,608971]
chr1	201009349	201009851	1	7	2	   0.502	0.127	CACNA1S	0.01702				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201030385	201030606	3	3	1	   0.221	0.127	CACNA1S	0.01468				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	201056944	201058601	3	5	2	   1.657	0.115	CACNA1S	0.00661				114208_[CACNA1S_Hypokalemic_periodic_paralysis,type_1,170400/Malignant_hyperthermia_susceptibility_5,601887/Thyrotoxic_periodic_paralysis,susceptibility_to,1,188580]
chr1	209790745	209790941	1	3	1	   0.196	0.115	LAMB3	0.01418				150310_[LAMB3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Amelogenesis_imperfecta,type_IA,104530]
chr1	209798983	209799381	3	4	1	   0.398	0.070	LAMB3	0.00667				150310_[LAMB3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Amelogenesis_imperfecta,type_IA,104530]
chr1	209800202	209800333	1	3	1	   0.131	0.089	LAMB3	0.00358				150310_[LAMB3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Amelogenesis_imperfecta,type_IA,104530]
chr1	209803072	209806131	1	3	3	   3.059	0.038	LAMB3	0.00899				150310_[LAMB3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Amelogenesis_imperfecta,type_IA,104530]
chr1	216465507	216465722	3	5	1	   0.215	0.083	USH2A	0.00124				608400_[USH2A_Usher_syndrome,type_2A,276901/Retinitis_pigmentosa_39,613809]
chr1	225592096	225592418	1	2	2	   0.322	0.197	LBR	0.06169				600024_[LBR_Pelger-Huet_anomaly,169400/Greenberg_skeletal_dysplasia,215140/Reynolds_syndrome,613471/Pelger-Huet_anomaly_with_mild_skeletal_anomalies,618019]
chr1	225607407	225609989	1	4	2	   2.582	0.134	LBR	0.03930				600024_[LBR_Pelger-Huet_anomaly,169400/Greenberg_skeletal_dysplasia,215140/Reynolds_syndrome,613471/Pelger-Huet_anomaly_with_mild_skeletal_anomalies,618019]
chr1	226574017	226576466	3	4	2	   2.449	0.140	PARP1	0.02970				
chr1	227153362	227165234	1	6	2	  11.872	0.121	COQ8A	0.00447				606980_[COQ8A_Coenzyme_Q10_deficiency,primary,4,612016]
chr1	229566983	229568884	3	6	6	   1.901	0.255	ACTA1	0.02519				102610_[ACTA1_Nemaline_myopathy_3,autosomal_dominant_or_recessive,161800/Myopathy,actin,congenital,with_excess_of_thin_myofilaments,161800/Myopathy,actin,congenital,with_cores,161800/Myopathy,congenital,with_fiber-type_disproportion_1,255310/Myopathy,scapulohumeroperoneal,616852]
chr1	231402013	231402163	1	4	1	   0.150	0.172	GNPAT	0.00922				602744_[GNPAT_Rhizomelic_chondrodysplasia_punctata,type_2,222765]
chr1	235860373	235866287	1	6	2	   5.914	0.159	LYST	0.01034				606897_[LYST_Chediak-Higashi_syndrome,214500]
chr1	236979739	236979853	1	3	1	   0.114	0.127	MTR	0.01367				156570_[MTR_Homocystinuria-megaloblastic_anemia,cblG_complementation_type,250940/Neural_tube_defects,folate-sensitive,susceptibility_to,601634]
chr1	237001704	237013833	3	3	2	  12.129	0.064	MTR	0.00926				156570_[MTR_Homocystinuria-megaloblastic_anemia,cblG_complementation_type,250940/Neural_tube_defects,folate-sensitive,susceptibility_to,601634]
chr1	241667332	241667555	3	5	1	   0.223	0.076	FH	0.00225				136850_[FH_Fumarase_deficiency,606812/Leiomyomatosis_and_renal_cell_cancer,150800]
chr2	11935524	11935623	1	4	1	   0.099	0.127	LPIN1	0.00540				605518_[LPIN1_Myoglobinuria,acute_recurrent,autosomal_recessive,268200]
chr2	11960527	11960650	3	4	1	   0.123	0.064	LPIN1	0.00519				605518_[LPIN1_Myoglobinuria,acute_recurrent,autosomal_recessive,268200]
chr2	44187670	44187783	3	5	1	   0.113	0.134	LRPPRC	0.00231				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	44206955	44209583	1	4	2	   2.628	0.083	LRPPRC	0.01894				607544_[LRPPRC_Leigh_syndrome,French-Canadian_type,220111]
chr2	46524531	46574212	3	4	2	  49.681	0.140	EPAS1	0.03004				603349_[EPAS1_Erythrocytosis,familial,4,611783]
chr2	71783085	71783211	1	4	1	   0.126	0.127	DYSF	0.00447				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71838365	71838486	3	5	1	   0.121	0.051	DYSF	0.00361				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	71909650	71913903	3	6	2	   4.253	0.083	DYSF	0.00026				603009_[DYSF_Muscular_dystrophy,limb-girdle,autosomal_recessive_2,253601/Myopathy,distal,with_anterior_tibial_onset,606768/Miyoshi_muscular_dystrophy_1,254130]
chr2	74590111	74592794	1	9	4	   2.683	0.102	DCTN1	0.00421				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	74605117	74605382	1	3	1	   0.265	0.121	DCTN1	0.00729				601143_[DCTN1_Neuropathy,distal_hereditary_motor,type_VIIB,607641/Amyotrophic_lateral_sclerosis,susceptibility_to,105400/Perry_syndrome,168605]
chr2	85894219	85895384	1	5	3	   1.165	0.121	SFTPB	0.00421				178640_[SFTPB_Surfactant_metabolism_dysfunction,pulmonary,1,265120]
chr2	86459738	86459935	3	6	1	   0.197	0.166	REEP1	0.00082				609139_[REEP1_Spastic_paraplegia_31,autosomal_dominant,610250/Neuronopathy,distal_hereditary_motor,type_VB,614751]
chr2	87016436	87017814	3	3	2	   1.378	0.070	CD8A	0.01896	yes			186910_[CD8A_CD8_deficiency,familial,608957]
chr2	88876062	88883070	1	5	3	   7.008	0.045	EIF2AK3	0.02371				604032_[EIF2AK3_Wolcott-Rallison_syndrome,226980]
chr2	98350859	98351929	3	4	2	   1.070	0.108	ZAP70	0.01812				176947_[ZAP70_Autoimmune_disease,multisystem,infantile-onset,2,617006/Immunodeficiency_48,269840]
chr2	99155981	99156148	1	4	1	   0.167	0.153	INPP4A	0.00839				
chr2	99160330	99162546	3	3	2	   2.216	0.076	INPP4A	0.05597				
chr2	99181093	99182239	1	6	2	   1.146	0.096	INPP4A	0.00484				
chr2	106468194	106468363	3	6	1	   0.169	0.121	NCK2	0.00084			NCK2	
chr2	109370271	109370437	3	4	1	   0.166	0.127	RANBP2	0.00509				601181_[RANBP2_Encephalopathy,acute,infection-induced,3,susceptibility_to,608033]
chr2	109397715	109397895	3	3	1	   0.180	0.064	RANBP2	0.00478				601181_[RANBP2_Encephalopathy,acute,infection-induced,3,susceptibility_to,608033]
chr2	110886753	110886846	1	4	1	   0.093	0.140	NPHP1	0.00777			NPHP1	607100_[NPHP1_Nephronophthisis_1,juvenile,256100/Senior-Loken_syndrome-1,266900/Joubert_syndrome_4,609583]
chr2	113994168	113994308	4	7	1	   0.140	0.115	PAX8,PAX8-AS1	0.00044			PAX8	167415_[PAX8_Hypothyroidism,congenital,due_to_thyroid_dysgenesis_or_hypoplasia,218700]
chr2	121740282	121740466	1	4	1	   0.184	0.096	GLI2	0.00667			GLI2	165230_[GLI2_Holoprosencephaly_9,610829/Culler-Jones_syndrome,615849]
chr2	127811471	127825841	3	10	7	  14.370	0.076	BIN1	0.00399				601248_[BIN1_Centronuclear_myopathy_2,255200]
chr2	149806818	149806986	1	4	1	   0.168	0.083	KIF5C	0.00231			KIF5C	604593_[KIF5C_Cortical_dysplasia,complex,with_other_brain_malformations_2,615282]
chr2	149850925	149851062	1	5	1	   0.137	0.064	KIF5C	0.00131			KIF5C	604593_[KIF5C_Cortical_dysplasia,complex,with_other_brain_malformations_2,615282]
chr2	152348891	152349018	1	6	1	   0.127	0.102	NEB	0.00115				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152387498	152388420	3	4	2	   0.922	0.096	NEB	0.03955				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152470780	152471111	3	4	1	   0.331	0.172	NEB	0.01116				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152482038	152490489	3	12	7	   8.451	0.096	NEB	0.00667				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152496859	152499205	3	5	2	   2.346	0.134	NEB	0.00839				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152500322	152500653	3	4	1	   0.331	0.108	NEB	0.00650				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152507078	152507409	3	4	1	   0.331	0.108	NEB	0.00697				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152521005	152521132	1	3	1	   0.127	0.102	NEB	0.00693				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152525531	152527753	3	5	2	   2.222	0.076	NEB	0.00528				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152537234	152537352	3	3	1	   0.118	0.070	NEB	0.00404				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152548368	152548690	3	2	2	   0.322	0.166	NEB	0.06453				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152579886	152581485	3	4	3	   1.599	0.064	NEB	0.01223				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	152590216	152590319	1	4	1	   0.103	0.064	NEB	0.00309				161650_[NEB_Nemaline_myopathy_2,autosomal_recessive,256030]
chr2	167142836	167143143	1	4	1	   0.307	0.057	SCN9A	0.00315				603415_[SCN9A_Erythermalgia,primary,133020/Paroxysmal_extreme_pain_disorder,167400,/Insensitivity_to_pain,congenital,243000/Febrile_seizures,familial,3B,613863/Epilepsy,generalized,with_febrile_seizures_plus,type_7,613863/Small_fiber_neuropathy,133020/Dravet_syndrome,modifier_of,607208/HSAN2D,autosomal_recessive,243000]
chr2	169836366	169836499	1	3	1	   0.133	0.064	ABCB11	0.00720				603201_[ABCB11_Cholestasis,progressive_familial_intrahepatic_2,601847/Cholestasis,benign_recurrent_intrahepatic,2,605479]
chr2	170009299	170009484	3	4	1	   0.185	0.102	LRP2	0.00421			LRP2	600073_[LRP2_Donnai-Barrow_syndrome,222448]
chr2	170029596	170029744	3	4	1	   0.148	0.038	LRP2	0.00393			LRP2	600073_[LRP2_Donnai-Barrow_syndrome,222448]
chr2	173338773	173339860	3	4	2	   1.087	0.070	ITGA6	0.00404				147556_[ITGA6_Epidermolysis_bullosa,junctional,with_pyloric_stenosis,226730]
chr2	178310264	178310364	1	4	1	   0.100	0.064	AGPS	0.00484				603051_[AGPS_Rhizomelic_chondrodysplasia_punctata,type_3,600121]
chr2	179449789	179450084	1	4	1	   0.295	0.140	TTN,TTN-AS1	0.00540				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179457492	179457820	1	3	1	   0.328	0.096	TTN,TTN-AS1	0.00542				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179482042	179482249	1	4	1	   0.207	0.204	TTN,TTN-AS1	0.00729				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179534935	179537440	1	2	5	   2.505	0.096	TTN,TTN-AS1	0.08096				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179549623	179550067	1	3	2	   0.444	0.121	TTN,TTN-AS1	0.06138				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179552828	179552961	3	3	1	   0.133	0.121	TTN,TTN-AS1	0.00534				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179633390	179634676	3	3	2	   1.286	0.102	TTN,TTN-AS1	0.00499				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179641866	179642712	1	3	3	   0.846	0.070	TTN	0.01321				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	179669269	179672160	1	5	2	   2.891	0.140	TTN	0.01852				188840_[TTN_Cardiomyopathy,familial_hypertrophic,9,613765/Cardiomyopathy,dilated,1G,604145/Tibial_muscular_dystrophy,tardive,600334/Muscular_dystrophy,limb-girdle,autosomal_recessive_10,608807/Myopathy,proximal,with_early_respiratory_muscle_involvement,603689/Salih_myopathy,611705]
chr2	202572582	202574771	1	3	2	   2.189	0.083	ALS2	0.05573				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	202606387	202606587	1	4	1	   0.200	0.083	ALS2	0.00371				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	202608971	202609162	3	3	1	   0.191	0.057	ALS2	0.00346				606352_[ALS2_Amyotrophic_lateral_sclerosis_2,juvenile,205100/Primary_lateral_sclerosis,juvenile,606353/Spastic_paralysis,infantile_onset_ascending,607225]
chr2	207631358	207632204	1	6	1	   0.846	0.038	FASTKD2	0.00034				612322_[FASTKD2_Mitochondrial_complex_IV_deficiency,220110]
chr2	211442135	211442244	3	3	1	   0.109	0.070	CPS1	0.00471				608307_[CPS1_Carbamoylphosphate_synthetase_I_deficiency,237300/Pulmonary_hypertension,neonatal,susceptibility_to,615371/Venoocclusive_disease_after_bone_marrow_transplantation]
chr2	211466916	211467064	1	3	1	   0.148	0.089	CPS1	0.00747				608307_[CPS1_Carbamoylphosphate_synthetase_I_deficiency,237300/Pulmonary_hypertension,neonatal,susceptibility_to,615371/Venoocclusive_disease_after_bone_marrow_transplantation]
chr2	215815593	215815817	3	7	1	   0.224	0.115	ABCA12	0.00225				607800_[ABCA12_Ichthyosis,congenital,autosomal_recessive_4A,601277/Ichthyosis,congenital,autosomal_recessive_4B_(harlequin),242500]
chr2	217293309	217293515	1	3	1	   0.206	0.102	SMARCAL1	0.02697				606622_[SMARCAL1_Schimke_immunoosseous_dysplasia,242900]
chr2	220025432	220025597	3	3	1	   0.165	0.159	NHEJ1	0.00689				611290_[NHEJ1_Severe_combined_immunodeficiency_with_microcephaly,growth_retardation,and_sensitivity_to_ionizing_radiation,611291]
chr2	227896854	227912275	1	6	5	  15.421	0.197	COL4A4	0.03723	yes			120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	227919300	227945275	1	7	8	  25.975	0.134	COL4A4	0.11518				120131_[COL4A4_Alport_syndrome,autosomal_recessive,203780/Hematuria,familial_benign]
chr2	228157897	228168870	1	8	7	  10.973	0.089	COL4A3	0.03608			COL4A3	120070_[COL4A3_Alport_syndrome,autosomal_recessive,203780/Hematuria,benign_familial,141200/Alport_syndrome,autosomal_dominant,104200]
chr2	228175482	228175674	1	4	1	   0.192	0.108	COL4A3	0.01100			COL4A3	120070_[COL4A3_Alport_syndrome,autosomal_recessive,203780/Hematuria,benign_familial,141200/Alport_syndrome,autosomal_dominant,104200]
chr2	233394639	233396183	3	4	2	   1.544	0.108	CHRND	0.00010				100690_[CHRND_Myasthenic_syndrome,congenital,1A,slow-channel,601462/Myasthenic_syndrome,congenital,1B,fast-channel,608930/Multiple_pterygium_syndrome,lethal_type,253290],100720_[CHRND_Myasthenic_syndrome,congenital,3A,slow-channel,616321/Myasthenic_syndrome,congenital,3B,fast-channel,616322/Myasthenic_syndrome,congenital,3C,associated_with_acetylcholine_receptor_deficiency,616323/Multiple_pterygium_syndrome,lethal_type,253290]
chr2	238268721	238268812	3	5	1	   0.091	0.108	COL6A3	0.00243				120250_[COL6A3_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090/Dystonia_27,616411]
chr2	240002781	240003927	1	3	2	   1.146	0.115	HDAC4	0.05597			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240029736	240029889	1	5	1	   0.153	0.083	HDAC4	0.00253			HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	240111519	240158370	3	10	2	  46.851	0.121	HDAC4	0.00020	yes		HDAC4	600430_[HDAC4_Chromosome_2q37_deletion_syndrome]
chr2	241535726	241538536	1	3	3	   2.810	0.057	CAPN10	0.00729				605286_[CAPN10_Diabetes_mellitus,noninsulin-dependent_1,601283]
chr3	4452539	4452672	3	4	1	   0.133	0.064	SUMF1	0.00732			SUMF1	607939_[SUMF1_Multiple_sulfatase_deficiency,272200]
chr3	4829621	4836881	3	7	2	   7.260	0.064	ITPR1	0.00009			ITPR1	147265_[ITPR1_Spinocerebellar_ataxia_15,606658/Spinocerebellar_ataxia_29,congenital_nonprogressive,117360/Gillespie_syndrome,206700]
chr3	10084233	10084357	3	5	1	   0.124	0.134	FANCD2	0.00316				613984_[FANCD2_Fanconi_anemia,complementation_group_D2,227646]
chr3	10101968	10102097	3	5	1	   0.129	0.083	FANCD2	0.00358				613984_[FANCD2_Fanconi_anemia,complementation_group_D2,227646]
chr3	12626336	12626490	1	4	1	   0.154	0.108	RAF1	0.00393	yes		RAF1	164760_[RAF1_Noonan_syndrome_5,611553/LEOPARD_syndrome_2,611554/Cardiomyopathy,dilated,1NN,615916]
chr3	12653439	12660256	1	3	2	   6.817	0.115	RAF1	0.02226	yes		RAF1	164760_[RAF1_Noonan_syndrome_5,611553/LEOPARD_syndrome_2,611554/Cardiomyopathy,dilated,1NN,615916]
chr3	15495326	15497536	3	8	2	   2.210	0.051	COLQ	0.00108				603033_[COLQ_Myasthenic_syndrome,congenital,5,603034]
chr3	33138493	33138704	5	4	1	   0.211	0.255	GLB1	0.00404				611458_[GLB1_GM1-gangliosidosis,type_I,230500/GM1-gangliosidosis,type_II,230600/GM1-gangliosidosis,type_III,230650/Mucopolysaccharidosis_type_IVB_(Morquio),253010]
chr3	41275620	41278210	1	3	4	   2.590	0.057	CTNNB1	0.00245				116806_[CTNNB1_Mental_retardation,autosomal_dominant_19,615075/Colorectal_cancer,somatic,114500/Pilomatricoma,somatic,132600/Ovarian_cancer,somatic,167000/Hepatocellular_carcinoma,somatic,114550/Medulloblastoma,somatic,155255/Exudative_vitreoretinopathy_7,617572]
chr3	46942505	46942585	1	3	1	   0.080	0.127	PTH1R	0.00445				168468_[PTH1R_Metaphyseal_chondrodysplasia,Murk_Jansen_type,156400/Chondrodysplasia,Blomstrand_type,215045/Eiken_syndrome,600002/Failure_of_tooth_eruption,primary,125350]
chr3	46944006	46944167	3	3	1	   0.161	0.121	PTH1R	0.01208				168468_[PTH1R_Metaphyseal_chondrodysplasia,Murk_Jansen_type,156400/Chondrodysplasia,Blomstrand_type,215045/Eiken_syndrome,600002/Failure_of_tooth_eruption,primary,125350]
chr3	48605513	48606298	1	6	2	   0.785	0.070	COL7A1	0.00422				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	48606798	48606889	3	4	1	   0.091	0.102	COL7A1	0.00346				120120_[COL7A1_Epidermolysis_bullosa_dystrophica,AD,131750/Epidermolysis_bullosa_dystrophica,AR,226600/Epidermolysis_bullosa,pretibial,131850/EBD,Bart_type,132000/EBD,localisata_variant/Transient_bullous_of_the_newborn,131705/Epidermolysis_bullosa_pruriginosa,604129/Toenail_dystrophy,isolated,607523/EBD_inversa,226600]
chr3	58084428	58084645	3	8	1	   0.217	0.115	FLNB	0.00020				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58110049	58111480	1	4	2	   1.431	0.134	FLNB	0.02921				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58116458	58117756	1	4	2	   1.298	0.108	FLNB	0.03120				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58140508	58141812	1	3	2	   1.304	0.076	FLNB	0.01272				603381_[FLNB_Spondylocarpotarsal_synostosis_syndrome,272460/Larsen_syndrome,150250/Atelosteogenesis,type_I,108720/Atelosteogenesis,type_III,108721/Boomerang_dysplasia,112310]
chr3	58415425	58415975	1	6	2	   0.550	0.153	PDHB	0.04494				179060_[PDHB_Pyruvate_dehydrogenase_E1-beta_deficiency,614111]
chr3	63884065	63898911	3	4	2	  14.846	0.115	ATXN7	0.01867				607640_[ATXN7_Spinocerebellar_ataxia_7,164500]
chr3	81695533	81695643	1	4	1	   0.110	0.127	GBE1	0.00720				607839_[GBE1_Glycogen_storage_disease_IV,232500/Polyglucosan_body_disease,adult_form,263570]
chr3	121514294	121516084	1	4	2	   1.790	0.134	IQCB1	0.05513				609237_[IQCB1_Senior-Loken_syndrome_5,609254]
chr3	121547307	121547489	3	5	1	   0.182	0.051	IQCB1	0.00170				609237_[IQCB1_Senior-Loken_syndrome_5,609254]
chr3	128603486	128603599	1	5	1	   0.113	0.083	ACAD9	0.00404				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	128627806	128627952	1	4	1	   0.146	0.108	ACAD9	0.00309				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	128628177	128629002	3	6	2	   0.825	0.102	ACAD9,KIAA1257	0.00399				611103_[ACAD9_Mitochondrial_complex_I_deficiency,nuclear_type_20,611126]
chr3	139066992	139067176	3	4	1	   0.184	0.083	MRPS22	0.00509				605810_[MRPS22_Combined_oxidative_phosphorylation_deficiency_5,611719/Ovarian_dysgenesis_7,618117]
chr3	142279095	142280273	3	3	2	   1.178	0.083	ATR	0.00081			ATR	601215_[ATR_Seckel_syndrome_1,210600/Cutaneous_telangiectasia_and_cancer_syndrome,familial,614564]
chr3	158378653	158383273	1	3	2	   4.620	0.089	GFM1	0.00663				606639_[GFM1_Combined_oxidative_phosphorylation_deficiency_1,609060]
chr3	159996971	159997162	1	5	1	   0.191	0.146	IFT80	0.00515				611177_[IFT80_Short-rib_thoracic_dysplasia_2_with_or_without_polydactyly,611263]
chr3	159998445	159998612	3	5	1	   0.167	0.108	IFT80	0.00404				611177_[IFT80_Short-rib_thoracic_dysplasia_2_with_or_without_polydactyly,611263]
chr3	183855398	183855873	1	2	2	   0.475	0.089	EIF2B5	0.00465				603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896]
chr3	184071028	184071593	1	3	2	   0.565	0.096	CLCN2,EIF2B5	0.01425			CLCN2	603945_[EIF2B5_Leukoencephalopathy_with_vanishing_white_matter,603896/Ovarioleukodystrophy,603896],600570_[CLCN2_Epilepsy,juvenile_myoclonic,susceptibility_to,8,607628/Epilepsy,juvenile_absence,susceptibility_to,2,607628/Epilepsy,idiopathic_generalized,susceptibility_to,11,607628/Leukoencephalopathy_with_ataxia,615651/Hyperaldosteronism,familial,type_II,605635]
chr3	196792569	196803566	3	5	2	  10.997	0.057	DLG1	0.00688			DLG1	
chr3	196857388	196857552	3	4	1	   0.164	0.076	DLG1	0.00773			DLG1	
chr3	197421236	197421466	3	11	1	   0.230	0.096	RUBCN	0.00007				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197431403	197431582	1	4	1	   0.179	0.178	RUBCN	0.00814				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr3	197444838	197476578	1	7	2	  31.740	0.064	RUBCN,FYTTD1	0.00346				613516_[RUBCN_Spinocerebellar_ataxia,autosomal_recessive_15,615705]
chr4	994660	997423	3	7	5	   2.763	0.248	IDUA	0.01377				252800_[IDUA_Mucopolysaccharidosis_Ih,607014/Mucopolysaccharidosis_Is,607016/Mucopolysaccharidosis_Ih/s,607015]
chr4	1803084	1804801	3	4	4	   1.717	0.299	FGFR3	0.02384			FGFR3	134934_[FGFR3_Achondroplasia,100800/Hypochondroplasia,146000/Thanatophoric_dysplasia,type_I,187600/Crouzon_syndrome_with_acanthosis_nigricans,612247/Muenke_syndrome,602849/Bladder_cancer,somatic,109800/Colorectal_cancer,somatic,114500/Cervical_cancer,somatic,603956/LADD_syndrome,149730/CATSHL_syndrome,610474/Nevus,epidermal,somatic,162900/Thanatophoric_dysplasia,type_II,187601/Spermatocytic_seminoma,somatic,273300/SADDAN,616482]
chr4	1952789	1952940	3	4	1	   0.151	0.115	NSD2	0.00540			NSD2	
chr4	1978192	1978416	3	4	1	   0.224	0.102	NSD2	0.00367			NSD2	
chr4	1986525	1986656	4	8	1	   0.131	0.153	NELFA	0.00020			NELFA	
chr4	1987831	1991606	3	7	4	   3.775	0.057	NELFA,MIR943	0.01311			NELFA	
chr4	5617139	5617281	3	3	1	   0.142	0.108	EVC2	0.00967			EVC2	607261_[EVC2_Ellis-van_Creveld_syndrome,225500/Weyers_acrofacial_dysostosis,193530]
chr4	5667232	5667386	3	4	1	   0.154	0.115	EVC2	0.00436			EVC2	607261_[EVC2_Ellis-van_Creveld_syndrome,225500/Weyers_acrofacial_dysostosis,193530]
chr4	5798739	5803831	1	3	2	   5.092	0.121	EVC	0.05945				604831_[EVC_Ellis-van_Creveld_syndrome,225500/Weyers_acrofacial_dysostosis,193530]
chr4	6292914	6293104	3	4	1	   0.190	0.064	WFS1	0.00471			WFS1	606201_[WFS1_Wolfram_syndrome_1,222300/Deafness,autosomal_dominant_6/14/38,600965/Wolfram-like_syndrome,autosomal_dominant,614296/Diabetes_mellitus,noninsulin-dependent,association_with,125853/Cataract_41,116400]
chr4	15564968	15565155	3	5	1	   0.187	0.025	CC2D2A	0.00373			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	15591158	15591312	3	4	1	   0.154	0.070	CC2D2A	0.00471			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	15597698	15597840	1	3	1	   0.142	0.121	CC2D2A	0.00978			CC2D2A	612013_[CC2D2A_Joubert_syndrome_9,612285/Meckel_syndrome_6,612284/COACH_syndrome,216360]
chr4	79188385	79199908	3	7	2	  11.523	0.134	FRAS1	0.00828				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79300870	79305307	1	6	2	   4.437	0.121	FRAS1	0.00612				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	79351436	79351581	1	3	1	   0.145	0.115	FRAS1	0.01389				607830_[FRAS1_Fraser_syndrome_1,219000]
chr4	87696314	87696505	1	3	1	   0.191	0.134	PTPN13	0.01719				
chr4	88977228	88977429	1	4	1	   0.201	0.089	PKD2	0.00574			PKD2	173910_[PKD2_Polycystic_kidney_disease_2,613095]
chr4	88989040	88996121	3	9	2	   7.081	0.070	PKD2	0.00019			PKD2	173910_[PKD2_Polycystic_kidney_disease_2,613095]
chr4	122754376	122754560	1	4	1	   0.184	0.127	BBS7	0.00839				607590_[BBS7_Bardet-Biedl_syndrome_7,615984]
chr4	128863190	128865157	1	6	2	   1.967	0.070	MFSD8	0.01095				611124_[MFSD8_Ceroid_lipofuscinosis,neuronal,7,610951/Macular_dystrophy_with_central_cone_involvement,616170]
chr4	149115887	149116023	1	3	1	   0.136	0.166	NR3C2	0.00839				600983_[NR3C2_Pseudohypoaldosteronism_type_I,autosomal_dominant,177735/Hypertension,early-onset,autosomal_dominant,with_exacerbation_in_pregnancy,605115]
chr4	187157925	187158104	3	3	1	   0.179	0.083	KLKB1	0.00664				229000_[KLKB1_Fletcher_factor_(prekallikrein)_deficiency,612423]
chr5	225524	225687	3	4	1	   0.163	0.127	SDHA	0.00490				600857_[SDHA_Leigh_syndrome,256000/Mitochondrial_respiratory_chain_complex_II_deficiency,252011/Cardiomyopathy,dilated,1GG,613642/Paragangliomas_5,614165]
chr5	235249	235464	1	4	1	   0.215	0.127	SDHA	0.00813				600857_[SDHA_Leigh_syndrome,256000/Mitochondrial_respiratory_chain_complex_II_deficiency,252011/Cardiomyopathy,dilated,1GG,613642/Paragangliomas_5,614165]
chr5	251443	251593	3	5	1	   0.150	0.096	SDHA	0.00313				600857_[SDHA_Leigh_syndrome,256000/Mitochondrial_respiratory_chain_complex_II_deficiency,252011/Cardiomyopathy,dilated,1GG,613642/Paragangliomas_5,614165]
chr5	1432569	1432823	3	8	1	   0.254	0.140	SLC6A3	0.00019				126455_[SLC6A3_Nicotine_dependence,protection_against,188890/Parkinsonism-dystonia,infantile,1,613135]
chr5	6599342	6607035	3	6	5	   7.693	0.070	NSUN2	0.08059				610916_[NSUN2_Mental_retardation,autosomal_recessive_5,611091]
chr5	6611828	6611921	3	3	1	   0.093	0.006	NSUN2	0.00292				610916_[NSUN2_Mental_retardation,autosomal_recessive_5,611091]
chr5	10256057	10256275	1	4	1	   0.218	0.121	CCT5	0.00484				610150_[CCT5_Neuropathy,hereditary_sensory,with_spastic_paraplegia,256840]
chr5	11903919	11904120	4	3	1	   0.201	0.229	CTNND2	0.05489			CTNND2	
chr5	68840721	68840956	5	6	1	   0.235	0.268	OCLN	0.00045	yes	yes		602876_[OCLN_Pseudo-TORCH_syndrome_1,251290]
chr5	70892097	70895597	3	4	2	   3.500	0.102	MCCC2	0.00361				609014_[MCCC2_3-Methylcrotonyl-CoA_carboxylase_2_deficiency,210210]
chr5	70900173	70900305	3	3	1	   0.132	0.076	MCCC2	0.01262				609014_[MCCC2_3-Methylcrotonyl-CoA_carboxylase_2_deficiency,210210]
chr5	77477321	77477496	1	4	1	   0.175	0.140	AP3B1	0.00428				603401_[AP3B1_Hermansky-Pudlak_syndrome_2,608233]
chr5	89854607	89854744	4	3	1	   0.137	0.261	ADGRV1	0.00968			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	89938443	89938868	1	1	2	   0.425	0.153	ADGRV1	0.02843			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90012274	90016050	1	4	2	   3.776	0.089	ADGRV1	0.01934			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90069993	90072403	3	3	2	   2.410	0.064	ADGRV1	0.00991			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	90281151	90281349	3	7	1	   0.198	0.096	ADGRV1	0.00048			ADGRV1	602851_[ADGRV1_Febrile_seizures,familial,4,604352/Usher_syndrome,type_2C,605472/Usher_syndrome,type_2C,GPR98/PDZD7_digenic,605472]
chr5	126161670	126161809	1	4	1	   0.139	0.108	LMNB1	0.00253			LMNB1	150340_[LMNB1_Leukodystrophy,adult-onset,autosomal_dominant,169500]
chr5	127599107	127599358	3	3	1	   0.251	0.121	FBN2	0.00427				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	127680067	127680212	1	4	1	   0.145	0.064	FBN2	0.00231				612570_[FBN2_Contractural_arachnodactyly,congenital,121050/Macular_degeneration,early-onset,616118]
chr5	131729358	131729513	3	3	1	   0.155	0.019	SLC22A5	0.00383				603377_[SLC22A5_Carnitine_deficiency,systemic_primary,212140]
chr5	131953752	131953996	3	7	1	   0.244	0.121	RAD50	0.00054				604040_[RAD50_Nijmegen_breakage_syndrome-like_disorder,613078]
chr5	137217652	137217804	3	3	1	   0.152	0.108	MYOT	0.00723				604103_[MYOT_Myopathy,myofibrillar,3,609200/Myopathy,spheroid_body,182920]
chr5	147443525	147443672	1	5	1	   0.147	0.115	SPINK5	0.00399				605010_[SPINK5_Netherton_syndrome,256500]
chr5	147465958	147470801	3	12	4	   4.843	0.089	SPINK5	0.00045				605010_[SPINK5_Netherton_syndrome,256500]
chr5	147486590	147486737	3	4	1	   0.147	0.051	SPINK5	0.00309				605010_[SPINK5_Netherton_syndrome,256500]
chr5	148388404	148389965	1	6	2	   1.561	0.083	SH3TC2	0.00111				608206_[SH3TC2_Charcot-Marie-Tooth_disease,type_4C,601596/Mononeuropathy_of_the_median_nerve,mild,613353]
chr5	158749392	158749529	1	4	1	   0.137	0.108	IL12B	0.00339			IL12B	161561_[IL12B_Immunodeficiency_29,mycobacteriosis,614890]
chr5	161569160	161569332	3	6	1	   0.172	0.076	GABRG2	0.00073			GABRG2	137164_[GABRG2_Epilepsy,generalized,with_febrile_seizures_plus,type_3,611277/Epilepsy,childhood_absence,susceptibility_to,2,607681/Febrile_seizures,familial,8,611277]
chr5	176707556	176707845	1	3	1	   0.289	0.076	NSD1	0.00419			NSD1	606681_[NSD1_Sotos_syndrome_1,117550/Leukemia,acute_myeloid,601626]
chr6	7559449	7563023	1	3	2	   3.574	0.083	DSP	0.03815				125647_[DSP_Keratosis_palmoplantaris_striata_II,612908/Cardiomyopathy,dilated,with_woolly_hair_and_keratoderma,605676/Arrhythmogenic_right_ventricular_dysplasia_8,607450/Skin_fragility-woolly_hair_syndrome,607655/Epidermolysis_bullosa,lethal_acantholytic,609638/Dilated_cardiomyopathy_with_woolly_hair,keratoderma,and_tooth_agenesis,615821]
chr6	16753454	16753588	3	4	1	   0.134	0.096	ATXN1	0.00490			ATXN1	601556_[ATXN1_Spinocerebellar_ataxia_1,164400]
chr6	24503481	24505223	1	4	2	   1.742	0.159	ALDH5A1	0.06970				610045_[ALDH5A1_Succinic_semialdehyde_dehydrogenase_deficiency,271980]
chr6	31828955	31829978	1	3	2	   1.023	0.121	NEU1	0.04964				608272_[NEU1_Sialidosis,type_I,256550/Sialidosis,type_II,256550]
chr6	31830385	31830719	3	4	1	   0.334	0.166	NEU1	0.00624				608272_[NEU1_Sialidosis,type_I,256550/Sialidosis,type_II,256550]
chr6	31910992	31911314	1	3	2	   0.322	0.064	C2,CFB	0.00656				613927_[C2_C2_deficiency,217000/Macular_degeneration,age-related,14,reduced_risk_of,615489],138470_[CFB_Macular_degeneration,age-related,14,reduced_risk_of,615489/Hemolytic_uremic_syndrome,atypical,susceptibility_to,4,612924/Complement_factor_B_deficiency,615561]
chr6	31963486	31964848	1	4	5	   1.362	0.127	C4A	0.05244	yes	yes	C4A	120810_[C4A_C4a_deficiency,614380/Blood_group,Rodgers,614374]
chr6	31974387	31975823	1	4	6	   1.436	0.255	CYP21A1P	0.32788	yes	yes	CYP21A1P	
chr6	32007313	32008558	3	2	5	   1.245	0.191	CYP21A2	0.23222	yes	yes	CYP21A2	613815_[CYP21A2_Adrenal_hyperplasia,congenital,due_to_21-hydroxylase_deficiency,201910/Hyperandrogenism,nonclassic_type,due_to_21-hydroxylase_deficiency,201910]
chr6	32800100	32800248	1	3	1	   0.148	0.197	TAP2	0.01502				170261_[TAP2_Bare_lymphocyte_syndrome,type_I,due_to_TAP2_deficiency,604571]
chr6	32818087	32818304	1	6	1	   0.217	0.115	PSMB9,TAP1	0.00198				177045_[PSMB9_Proteasome-associated_autoinflammatory_syndrome_3,digenic,617591],170260_[TAP1_Bare_lymphocyte_syndrome,type_I,604571]
chr6	33408496	33408752	1	3	1	   0.256	0.140	SYNGAP1	0.02015			SYNGAP1	603384_[SYNGAP1_Mental_retardation,autosomal_dominant_5,612621]
chr6	33410656	33411747	3	6	1	   1.091	0.115	SYNGAP1	0.00202			SYNGAP1	603384_[SYNGAP1_Mental_retardation,autosomal_dominant_5,612621]
chr6	33414342	33414573	3	7	1	   0.231	0.153	SYNGAP1	0.00092			SYNGAP1	603384_[SYNGAP1_Mental_retardation,autosomal_dominant_5,612621]
chr6	35427098	35428405	3	2	3	   1.307	0.070	FANCE	0.01522				613976_[FANCE_Fanconi_anemia,complementation_group_E,600901]
chr6	42933970	42934195	1	3	1	   0.225	0.076	PEX6	0.00397				601498_[PEX6_Peroxisome_biogenesis_disorder_4A_(Zellweger),614862/Peroxisome_biogenesis_disorder_4B,614863/Heimler_syndrome_2,616617]
chr6	42945997	43550888	3	5	4	 604.891	0.025	PEX6,POLH	0.00421	yes	yes		601498_[PEX6_Peroxisome_biogenesis_disorder_4A_(Zellweger),614862/Peroxisome_biogenesis_disorder_4B,614863/Heimler_syndrome_2,616617],601646_[PPP2R5D_Mental_retardation,autosomal_dominant_35,616355],609577_[CUL7_3-M_syndrome_1,273750],610060_[POLR1C_Treacher_Collins_syndrome_3,248390/Leukodystrophy,hypomyelinating,11,616494],603968_[POLH_Xeroderma_pigmentosum,variant_type,278750]
chr6	49407909	49408076	1	4	1	   0.167	0.083	MMUT	0.00499				609058_[MUT_Methylmalonic_aciduria,mut(0)_type,251000]
chr6	51913280	51915103	1	3	2	   1.823	0.134	PKHD1	0.12055				606702_[PKHD1_Polycystic_kidney_disease_4,with_or_without_hepatic_disease,263200]
chr6	51918826	51920537	1	3	2	   1.711	0.140	PKHD1	0.06416				606702_[PKHD1_Polycystic_kidney_disease_4,with_or_without_hepatic_disease,263200]
chr6	52288475	52288975	1	4	2	   0.500	0.172	EFHC1	0.02540			EFHC1	608815_[EFHC1_Myoclonic_epilepsy,juvenile,susceptibility_to,1,254770/Epilepsy,juvenile_absence,susceptibility_to,1,607631]
chr6	52876825	52878790	3	6	2	   1.965	0.083	ICK	0.00124				612325_[ICK_Endocrine-cerebroosteodysplasia,612651/Epilepsy,juvenile_myoclonic,susceptibility_to,10,617924]
chr6	88224665	88226608	3	4	2	   1.943	0.057	RARS2	0.00919				611524_[RARS2_Pontocerebellar_hypoplasia,type_6,611523]
chr6	100896012	100896138	3	4	1	   0.126	0.140	SIM1	0.00723			SIM1	603128_[SIM1_Obesity,severe,601665]
chr6	101053434	101053586	1	3	1	   0.152	0.070	ASCC3	0.01849				
chr6	101328927	101329234	4	4	1	   0.307	0.248	ASCC3	0.00849				
chr6	102513662	102513813	3	4	1	   0.151	0.185	GRIK2	0.00697			GRIK2	138244_[GRIK2_Mental_retardation,autosomal_recessive,6,611092]
chr6	110943281	110943379	3	4	1	   0.098	0.057	CDK19	0.00211				
chr6	111136202	111136422	5	4	1	   0.220	0.344	CDK19	0.00689				
chr6	129621871	129635953	1	4	3	  14.082	0.140	LAMA2	0.05772				156225_[LAMA2_Muscular_dystrophy,limb-girdle,autosomal_recessive_23,618138/Muscular_dystrophy,congenital,merosin_deficient_or_partially_deficient,607855]
chr6	129636897	129637105	1	3	1	   0.208	0.096	LAMA2	0.00556				156225_[LAMA2_Muscular_dystrophy,limb-girdle,autosomal_recessive_23,618138/Muscular_dystrophy,congenital,merosin_deficient_or_partially_deficient,607855]
chr6	132201010	132201184	3	3	1	   0.174	0.083	ENPP1	0.00367				173335_[ENPP1_Diabetes_mellitus,non-insulin-dependent,susceptibility_to,125853/Obesity,susceptibility_to,601665/Arterial_calcification,generalized,of_infancy,1,208000/Hypophosphatemic_rickets,autosomal_recessive,2,613312/Cole_disease,615522]
chr6	143780212	143780363	3	3	1	   0.151	0.089	PEX3	0.00434				603164_[PEX3_Peroxisome_biogenesis_disorder_10A_(Zellweger),614882/Peroxisome_biogenesis_disorder_10B,617370]
chr6	152527293	152527507	1	5	1	   0.214	0.102	SYNE1	0.00471				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152602932	152614894	1	6	3	  11.962	0.108	SYNE1	0.00540	yes			608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152629614	152631663	1	4	2	   2.049	0.070	SYNE1	0.00425				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152671293	152671480	1	3	1	   0.187	0.083	SYNE1	0.01190				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	152725338	152728341	3	3	2	   3.003	0.064	SYNE1	0.00835				608441_[SYNE1_Spinocerebellar_ataxia,autosomal_recessive_8,610743/Emery-Dreifuss_muscular_dystrophy_4,autosomal_dominant,612998]
chr6	161128722	161128848	3	6	1	   0.126	0.115	PLG	0.00185				173350_[PLG_Dysplasminogenemia,217090/Plasminogen_deficiency,type_I,217090]
chr6	170870869	170871331	5	5	1	   0.462	0.465	TBP	0.00208				600075_[TBP_Spinocerebellar_ataxia_17,607136/Parkinson_disease,susceptibility_to,168600]
chr7	195544	195742	3	7	1	   0.198	0.127	FAM20C	0.00067				611061_[FAM20C_Raine_syndrome,259775]
chr7	23053534	30634769	3	4	2	7581.235	0.146	FAM126A,GARS,GARS-DT	0.00689	yes	yes	HOXA3,HOXA13	610531_[FAM126A_Leukodystrophy,hypomyelinating,5,610532],611119_[KLHL7_Retinitis_pigmentosa_42,612943/Cold-induced_sweating_syndrome_3,617055],604368_[GPNMB_Amyloidosis,primary_localized_cutaneous,3,617920],608798_[GSDME_Deafness,autosomal_dominant_5,600994],123970_[CYCS_Thrombocytopenia_4,612004],600124_[HNRNPA2B1_Inclusion_body_myopathy_with_early-onset_Paget_disease_with_or_without_frontotemporal_dementia_2,615422],614780_[SNX10_Osteopetrosis,autosomal_recessive_8,615085],142955_[HOXA1_Bosley-Salih-Alorainy_syndrome,601536/Athabaskan_brainstem_dysgenesis_syndrome,601536],604685_[HOXA2_Microtia,hearing_impairment,and_cleft_palate_(AR),612290/Microtia_with_or_without_hearing_impairment_(AD),612290],142958_[HOXA11_Radioulnar_synostosis_with_amegakaryocytic_thrombocytopenia_1,605432],142959_[HOXA13_Hand-foot-uterus_syndrome,140000/Guttmacher_syndrome,176305],614505_[FKBP14_Ehlers-Danlos_syndrome,kyphoscoliotic_type,2,614557],600287_[GARS_Charcot-Marie-Tooth_disease,type_2D,601472/Neuropathy,distal_hereditary_motor,type_VA,600794]
chr7	42116341	42116466	3	5	1	   0.125	0.089	GLI3	0.00151			GLI3	165240_[GLI3_Greig_cephalopolysyndactyly_syndrome,175700/Pallister-Hall_syndrome,146510/Polydactyly,preaxial,type_IV,174700/Polydactyly,postaxial,types_A1_and_B,174200/Hypothalamic_hamartomas,somatic,241800]
chr7	44185086	44185339	1	3	1	   0.253	0.159	GCK	0.00992				138079_[GCK_MODY,type_II,125851/Diabetes_mellitus,noninsulin-dependent,late_onset,125853/Hyperinsulinemic_hypoglycemia,familial,3,602485/Diabetes_mellitus,permanent_neonatal,606176]
chr7	44191860	44193072	3	6	2	   1.212	0.108	GCK	0.00108				138079_[GCK_MODY,type_II,125851/Diabetes_mellitus,noninsulin-dependent,late_onset,125853/Hyperinsulinemic_hypoglycemia,familial,3,602485/Diabetes_mellitus,permanent_neonatal,606176]
chr7	65444704	65444908	3	6	1	   0.204	0.127	GUSB	0.00070				611499_[GUSB_Mucopolysaccharidosis_VII,253220]
chr7	65557534	66098441	1	11	3	 540.907	0.089	ASL,KCTD7	0.00091	yes	yes		608310_[ASL_Argininosuccinic_aciduria,207900],611725_[KCTD7_Epilepsy,progressive_myoclonic_3,with_or_without_intracellular_inclusions,611726]
chr7	73459542	73461107	1	3	2	   1.565	0.178	ELN	0.07204			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	73474206	73477564	3	11	3	   3.358	0.121	ELN,ELN-AS1	0.00020			ELN	130160_[ELN_Supravalvar_aortic_stenosis,185500/Cutis_laxa,autosomal_dominant,123700],194050_[ELN_Williams-Beuren_syndrome]
chr7	74146810	74147013	1	4	1	   0.203	0.159	GTF2I,STAG3L2	0.00661			GTF2I	
chr7	75614085	75614286	3	5	1	   0.201	0.140	POR	0.00371				124015_[POR_Antley-Bixler_syndrome_with_genital_anomalies_and_disordered_steroidogenesis,201750/Disordered_steroidogenesis_due_to_cytochrome_P450_oxidoreductase,613571]
chr7	87053212	87056246	1	3	2	   3.034	0.108	ABCB4	0.00987				171060_[ABCB4_Cholestasis,progressive_familial_intrahepatic_3,602347/Cholestasis,intrahepatic,of_pregnancy,3,614972/Gallbladder_disease_1,600803]
chr7	87076340	87076531	3	3	1	   0.191	0.115	ABCB4	0.01344				171060_[ABCB4_Cholestasis,progressive_familial_intrahepatic_3,602347/Cholestasis,intrahepatic,of_pregnancy,3,614972/Gallbladder_disease_1,600803]
chr7	92123791	92126101	1	3	2	   2.310	0.070	PEX1	0.01818				602136_[PEX1_Peroxisome_biogenesis_disorder_1A_(Zellweger),214100/Peroxisome_biogenesis_disorder_1B_(NALD/IRD),601539/Heimler_syndrome_1,234580]
chr7	103141182	103141379	1	3	1	   0.197	0.134	RELN	0.01476			RELN	600514_[RELN_Lissencephaly_2_(Norman-Roberts_type),257320/Epilepsy,familial_temporal_lobe,7,616436]
chr7	103155622	103155898	1	3	1	   0.276	0.070	RELN	0.01213			RELN	600514_[RELN_Lissencephaly_2_(Norman-Roberts_type),257320/Epilepsy,familial_temporal_lobe,7,616436]
chr7	103243741	103243947	3	5	1	   0.206	0.045	RELN	0.00434			RELN	600514_[RELN_Lissencephaly_2_(Norman-Roberts_type),257320/Epilepsy,familial_temporal_lobe,7,616436]
chr7	112112264	112112412	3	4	1	   0.148	0.089	IFRD1	0.01020				
chr7	114293971	114298332	3	5	2	   4.361	0.127	FOXP2	0.00400			FOXP2	605317_[FOXP2_Speech-language_disorder-1,602081]
chr7	114303495	114303584	1	3	1	   0.089	0.089	FOXP2	0.00830			FOXP2	605317_[FOXP2_Speech-language_disorder-1,602081]
chr7	117251625	117251872	3	7	1	   0.247	0.089	CFTR	0.00083				602421_[CFTR_Cystic_fibrosis,219700/Congenital_bilateral_absence_of_vas_deferens,277180/Sweat_chloride_elevation_without_CF/Pancreatitis,hereditary,167800/Hypertrypsinemia,neonatal/Bronchiectasis_with_or_without_elevated_sweat_chloride_1,modifier_of,211400]
chr7	128482275	128482438	3	3	1	   0.163	0.197	FLNC	0.00447	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128488605	128488781	3	3	1	   0.176	0.121	FLNC	0.01079	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128489375	128489642	3	5	1	   0.267	0.108	FLNC	0.00371	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	128496789	128496985	3	4	1	   0.196	0.070	FLNC	0.00361	yes			102565_[FLNC_Myopathy,myofibrillar,5,609524/Myopathy,distal,4,614065/Cardiomyopathy,familial_hypertrophic,26/Cardiomyopathy,familial_restrictive_5,617047]
chr7	139791594	139791887	1	4	1	   0.293	0.051	KDM7A	0.00639				
chr7	143028634	143036425	1	6	4	   7.791	0.089	CLCN1	0.00862			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	143039012	143039245	1	5	1	   0.233	0.096	CLCN1	0.00729			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	143043223	143043354	3	3	1	   0.131	0.127	CLCN1	0.00679			CLCN1	118425_[CLCN1_Myotonia_congenita,recessive,255700/Myotonia_congenita,dominant,160800/Myotonia_levior,recessive]
chr7	147926728	147926881	1	6	1	   0.153	0.076	CNTNAP2	0.00045			CNTNAP2	604569_[CNTNAP2_Cortical_dysplasia-focal_epilepsy_syndrome,610042/Autism_susceptibility_15,612100/Pitt-Hopkins_like_syndrome_1,610042]
chr7	155604507	155604977	3	7	1	   0.470	0.108	SHH	0.00243			SHH	600725_[SHH_Holoprosencephaly_3,142945/Single_median_maxillary_central_incisor,147250/Microphthalmia_with_coloboma_5,611638/Schizencephaly,269160]
chr8	1808053	1828340	3	7	5	  20.287	0.051	ARHGEF10	0.00812				608136_[ARHGEF10_Slowed_nerve_conduction_velocity,AD,608236]
chr8	6266790	6266901	3	4	1	   0.111	0.146	MCPH1	0.00991				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	6272276	6272414	1	5	1	   0.138	0.127	MCPH1	0.00346				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	6478965	6501150	1	8	2	  22.185	0.057	MCPH1	0.01116				607117_[MCPH1_Microcephaly_1,primary,autosomal_recessive,251200]
chr8	22020077	22020255	3	8	1	   0.178	0.121	SFTPC	0.00020				178620_[SFTPC_Surfactant_metabolism_dysfunction,pulmonary,2,610913]
chr8	22020939	22021069	1	5	1	   0.130	0.102	SFTPC	0.00253				178620_[SFTPC_Surfactant_metabolism_dysfunction,pulmonary,2,610913]
chr8	27637681	27637794	1	4	1	   0.113	0.115	ESCO2	0.00591				609353_[ESCO2_Roberts_syndrome,268300/SC_phocomelia_syndrome,269000]
chr8	33364737	33364849	3	6	1	   0.112	0.083	TTI2	0.00216				614426_[TTI2_Mental_retardation,autosomal_recessive_39,615541]
chr8	38277041	38282227	3	6	3	   5.186	0.115	FGFR1	0.01867			FGFR1	136350_[FGFR1_Pfeiffer_syndrome,101600/Jackson-Weiss_syndrome,123150/Hypogonadotropic_hypogonadism_2_with_or_without_anosmia,147950/Osteoglophonic_dysplasia,166250/Trigonocephaly_1,190440/Hartsfield_syndrome,615465/Encephalocraniocutaneous_lipomatosis,613001]
chr8	43013708	43014197	1	3	2	   0.489	0.102	HGSNAT	0.00515				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	43024306	43024395	1	4	1	   0.089	0.102	HGSNAT	0.00991				610453_[HGSNAT_Mucopolysaccharidosis_type_IIIC_(Sanfilippo_C),252930/Retinitis_pigmentosa_73,616544]
chr8	48701457	48701620	1	3	1	   0.163	0.210	PRKDC	0.01065				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48744365	48746967	3	6	2	   2.602	0.076	PRKDC	0.00727				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48748889	48749098	1	3	1	   0.209	0.025	PRKDC	0.00803				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	48841642	48841748	1	3	1	   0.106	0.051	PRKDC	0.00679				600899_[PRKDC_Immunodeficiency_26,with_or_without_neurologic_abnormalities,615966]
chr8	61741212	61741375	1	3	1	   0.163	0.038	CHD7	0.00373			CHD7	608892_[CHD7_CHARGE_syndrome,214800/Hypogonadotropic_hypogonadism_5_with_or_without_anosmia,612370]
chr8	75262608	75263711	3	4	2	   1.103	0.166	GDAP1	0.01796				605266_[GDAP1_Charcot-Marie-Tooth_disease,axonal,autosomal_dominant,type_2K,607831],606598_[GDAP1_Charcot-Marie-Tooth_disease,type_4A,214400/Charcot-Marie-Tooth_disease,axonal,with_vocal_cord_paresis,607706/Charcot-Marie-Tooth_disease,axonal,type_2K,607831/Charcot-Marie-Tooth_disease,recessive_intermediate,A,608340]
chr8	100123316	100123517	1	4	1	   0.201	0.108	VPS13B	0.01020			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	100221810	100286570	1	4	2	  64.760	0.217	VPS13B	0.07447			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	100589708	100589871	3	3	1	   0.163	0.102	VPS13B	0.00679			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	100830669	100830772	1	5	1	   0.103	0.083	VPS13B	0.00334			VPS13B	607817_[VPS13B_Cohen_syndrome,216550]
chr8	105441763	105441939	3	3	1	   0.176	0.115	DPYS	0.00436				613326_[DPYS_Dihydropyrimidinuria,222748]
chr8	133918923	133920595	1	4	2	   1.672	0.064	TG	0.01020				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	133980029	133980225	1	3	1	   0.196	0.140	TG	0.01130				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	134125656	134125857	1	7	1	   0.201	0.096	TG	0.00020				188450_[TG_Thyroid_dyshormonogenesis_3,274700/Autoimmune_thyroid_disease,susceptibility_to,3,608175],610931_[TG_Autoimmune_thyroid_disease,susceptibility_to,3,608175]
chr8	134262673	134269116	3	7	2	   6.443	0.096	NDRG1	0.00226				605262_[NDRG1_Charcot-Marie-Tooth_disease,type_4D,601455]
chr8	134296482	134309557	3	5	2	  13.075	0.121	NDRG1	0.00720				605262_[NDRG1_Charcot-Marie-Tooth_disease,type_4D,601455]
chr8	140714943	140743481	3	7	2	  28.538	0.115	KCNK9,TRAPPC9	0.00490			KCNK9	605874_[KCNK9_Birk-Barel_mental_retardation_dysmorphism_syndrome,612292],611966_[TRAPPC9_Mental_retardation,autosomal_recessive_13,613192]
chr8	143956363	143956738	3	3	2	   0.375	0.134	CYP11B1	0.02098			CYP11B1	610613_[CYP11B1_Adrenal_hyperplasia,congenital,due_to_11-beta-hydroxylase_deficiency,202010/Aldosteronism,glucocorticoid-remediable,103900]
chr8	143993936	143994311	3	2	2	   0.375	0.108	CYP11B2	0.03515	yes		CYP11B2	124080_[CYP11B2_Hypoaldosteronism,congenital,due_to_CMO_II_deficiency,610600/Hypoaldosteronism,congenital,due_to_CMO_I_deficiency,203400/Low_renin_hypertension,susceptibility_to/Aldosterone_to_renin_ratio_raised]
chr8	143995670	143996334	3	8	2	   0.664	0.140	CYP11B2	0.00185	yes		CYP11B2	124080_[CYP11B2_Hypoaldosteronism,congenital,due_to_CMO_II_deficiency,610600/Hypoaldosteronism,congenital,due_to_CMO_I_deficiency,203400/Low_renin_hypertension,susceptibility_to/Aldosterone_to_renin_ratio_raised]
chr8	144989311	145001060	3	4	2	  11.749	0.172	PLEC	0.08799				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr8	145017937	145018120	5	5	1	   0.183	0.280	PLEC	0.00404				601282_[PLEC_Epidermolysis_bullosa_simplex_with_muscular_dystrophy,226670/Epidermolysis_bullosa_simplex,Ogna_type,131950/Epidermolysis_bullosa_simplex_with_pyloric_atresia,612138/Muscular_dystrophy,limb-girdle,autosomal_recessive_17,613723/Epidermolysis_bullosa_simplex_with_nail_dystrophy,616487]
chr9	289500	304714	1	5	2	  15.214	0.121	DOCK8	0.02512	yes			611432_[DOCK8_Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700]
chr9	406920	414961	1	5	2	   8.041	0.089	DOCK8	0.00423				611432_[DOCK8_Hyper-IgE_recurrent_infection_syndrome,autosomal_recessive,243700]
chr9	731148	732627	3	6	2	   1.479	0.115	KANK1	0.00375			KANK1	607704_[KANK1_Cerebral_palsy,spastic_quadriplegic,2,612900]
chr9	2635443	2635582	3	5	1	   0.139	0.057	VLDLR	0.00209				192977_[VLDLR_Cerebellar_hypoplasia_and_mental_retardation_with_or_without_quadrupedal_locomotion_1,224050]
chr9	34647076	34647265	1	3	1	   0.189	0.127	GALT	0.01202				606999_[GALT_Galactosemia,230400]
chr9	34648321	34648463	1	5	1	   0.142	0.134	GALT	0.00491				606999_[GALT_Galactosemia,230400]
chr9	35064141	35065388	3	5	2	   1.247	0.070	VCP	0.00067				601023_[VCP_Inclusion_body_myopathy_with_early-onset_Paget_disease_and_frontotemporal_dementia_1,167320/Amyotrophic_lateral_sclerosis_14,with_or_without_frontotemporal_dementia,613954/Charcot-Marie-Tooth_disease,type_2Y,616687]
chr9	79865003	79865155	3	5	1	   0.152	0.108	VPS13A	0.00277				605978_[VPS13A_Choreoacanthocytosis,200150]
chr9	79984205	79984338	3	6	1	   0.133	0.115	VPS13A	0.00284				605978_[VPS13A_Choreoacanthocytosis,200150]
chr9	80020770	80020913	3	6	1	   0.143	0.051	VPS13A	0.00060				605978_[VPS13A_Choreoacanthocytosis,200150]
chr9	94809885	94810000	1	3	1	   0.115	0.108	SPTLC1	0.01764				605712_[SPTLC1_Neuropathy,hereditary_sensory_and_autonomic,type_IA,162400]
chr9	98240327	98241439	3	7	2	   1.112	0.096	PTCH1	0.00020			PTCH1	601309_[PTCH1_Basal_cell_nevus_syndrome,109400/Basal_cell_carcinoma,somatic,605462/Holoprosencephaly_7,610828]
chr9	130422299	130422397	3	6	1	   0.098	0.051	STXBP1	0.00066			STXBP1	602926_[STXBP1_Epileptic_encephalopathy,early_infantile,4,612164]
chr9	131346057	131346258	3	3	1	   0.201	0.070	SPTAN1	0.01708				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	131351078	131351232	3	3	1	   0.154	0.025	SPTAN1	0.00169				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	131381140	131381292	3	4	1	   0.152	0.166	SPTAN1	0.00667				182810_[SPTAN1_Epileptic_encephalopathy,early_infantile,5,613477]
chr9	135161800	135163748	1	6	2	   1.948	0.083	SETX	0.00404				608465_[SETX_Amyotrophic_lateral_sclerosis_4,juvenile,602433/Spinocerebellar_ataxia,autosomal_recessive_1,606002]
chr9	136287110	136287678	3	4	1	   0.568	0.102	ADAMTS13	0.00373				604134_[ADAMTS13_Thrombotic_thrombocytopenic_purpura,familial,274150]
chr9	136319527	136319751	1	5	1	   0.224	0.102	ADAMTS13	0.00201				604134_[ADAMTS13_Thrombotic_thrombocytopenic_purpura,familial,274150]
chr9	136409582	136419825	3	6	3	  10.243	0.115	ADAMTSL2	0.01206	yes			612277_[ADAMTSL2_Geleophysic_dysplasia_1,231050]
chr9	136438955	136439119	3	5	1	   0.164	0.146	ADAMTSL2	0.00290				612277_[ADAMTSL2_Geleophysic_dysplasia_1,231050]
chr9	139264192	139265163	1	4	3	   0.971	0.108	CARD9	0.00395				607212_[CARD9_Candidiasis,familial,2,autosomal_recessive,212050]
chr9	139323057	139325579	3	5	3	   2.522	0.115	INPP5E	0.02222				613037_[INPP5E_Mental_retardation,truncal_obesity,retinal_dystrophy,and_micropenis,610156/Joubert_syndrome_1,213300]
chr9	139730184	139732477	3	4	2	   2.293	0.172	RABL6	0.01702				
chr9	139734136	139982645	3	6	4	 248.509	0.076	RABL6,MAN1B1	0.01808	yes			604346_[MAN1B1_Mental_retardation,autosomal_recessive_15,614202]
chr9	140001131	140001909	3	3	2	   0.778	0.038	MAN1B1	0.00542				604346_[MAN1B1_Mental_retardation,autosomal_recessive_15,614202]
chr9	140646773	140646870	4	8	1	   0.097	0.096	EHMT1	0.00026			EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr9	140712502	140728986	3	3	2	  16.484	0.217	EHMT1	0.11211	yes		EHMT1	607001_[EHMT1_Kleefstra_syndrome_1,610253]
chr10	43615519	43617474	3	4	2	   1.955	0.248	RET	0.01913			RET	164761_[RET_Multiple_endocrine_neoplasia_IIA,171400/Medullary_thyroid_carcinoma,155240/Multiple_endocrine_neoplasia_IIB,162300/Central_hypoventilation_syndrome,congenital,209880/Pheochromocytoma,171300/Hirschsprung_disease,susceptibility_to,1,142623/Hirschsprung_disease,protection_against,142623]
chr10	73269829	73269991	3	4	1	   0.162	0.134	CDH23,CDH23-AS1	0.00389				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73439134	73442339	3	3	2	   3.205	0.172	CDH23	0.09270				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73490216	73492491	3	3	2	   2.275	0.096	C10ORF105,CDH23	0.01879				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	73569567	73569843	3	4	1	   0.276	0.096	CDH23	0.01383				605516_[CDH23_Usher_syndrome,type_1D,601067/Deafness,autosomal_recessive_12,601386/Usher_syndrome,type_1D/F_digenic,601067/Pituitary_adenoma_5,multiple_types,617540]
chr10	82034763	82034965	1	5	1	   0.202	0.115	MAT1A	0.00305				610550_[MAT1A_Hypermethioninemia,persistent,autosomal_dominant,due_to_methionine_adenosyltransferase_I/III_deficiency,250850/Methionine_adenosyltransferase_deficiency,autosomal_recessive,250850]
chr10	82043662	82043804	1	4	1	   0.142	0.121	MAT1A	0.01003				610550_[MAT1A_Hypermethioninemia,persistent,autosomal_dominant,due_to_methionine_adenosyltransferase_I/III_deficiency,250850/Methionine_adenosyltransferase_deficiency,autosomal_recessive,250850]
chr10	83635060	83635929	4	4	1	   0.869	0.166	NRG3	0.00720			NRG3	
chr10	88478474	88486019	1	4	2	   7.545	0.057	LDB3	0.00462				605906_[LDB3_Myopathy,myofibrillar,4,609452/Cardiomyopathy,dilated,1C,with_or_without_LVNC,601493/Cardiomyopathy,hypertrophic,24,601493/Left_ventricular_noncompaction_3,601493]
chr10	96039529	96043678	3	7	2	   4.149	0.127	PLCE1,PLCE1-AS1	0.00559				608414_[PLCE1_Nephrotic_syndrome,type_3,610725]
chr10	97599438	97599575	3	4	1	   0.137	0.166	ENTPD1,ENTPD1-AS1	0.00623				601752_[ENTPD1_Spastic_paraplegia_64,autosomal_recessive,615683]
chr10	101476095	101478267	1	5	2	   2.172	0.019	COX15	0.00720				603646_[COX15_Leigh_syndrome_due_to_cytochrome_c_oxidase_deficiency,256000/Cardioencephalomyopathy,fatal_infantile,due_to_cytochrome_c_oxidase_deficiency_2,615119]
chr10	105795222	105796400	1	3	2	   1.178	0.057	COL17A1	0.00361				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	105822006	105836197	3	5	4	  14.191	0.089	COL17A1	0.00346				113811_[COL17A1_Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa,junctional,localisata_variant,226650/Epithelial_recurrent_erosion_dystrophy,122400]
chr10	121431757	121432178	3	6	1	   0.421	0.089	BAG3	0.00077			BAG3	603883_[BAG3_Myopathy,myofibrillar,6,612954/Cardiomyopathy,dilated,1HH,613881]
chr10	123298096	123298239	3	4	1	   0.143	0.089	FGFR2	0.02192			FGFR2	176943_[FGFR2_Crouzon_syndrome,123500/Jackson-Weiss_syndrome,123150/Beare-Stevenson_cutis_gyrata_syndrome,123790/Pfeiffer_syndrome,101600/Apert_syndrome,101200/Saethre-Chotzen_syndrome,101400/Craniosynostosis,nonspecific/Gastric_cancer,somatic,613659/Craniofacial-skeletal-dermatologic_dysplasia,101600/Antley-Bixler_syndrome_without_genital_anomalies_or_disordered_steroidogenesis,207410/Scaphocephaly_and_Axenfeld-Rieger_anomaly/LADD_syndrome,149730/Scaphocephaly,maxillary_retrusion,and_mental_retardation,609579/Bent_bone_dysplasia_syndrome,614592]
chr11	1773972	1774910	3	5	1	   0.938	0.089	CTSD	0.00231				116840_[CTSD_Ceroid_lipofuscinosis,neuronal,10,610127]
chr11	1778544	1780879	3	6	3	   2.335	0.159	CTSD	0.05389				116840_[CTSD_Ceroid_lipofuscinosis,neuronal,10,610127]
chr11	2185149	2185632	3	4	1	   0.483	0.089	TH	0.00847			TH	191290_[TH_Segawa_syndrome,recessive,605407]
chr11	2415315	2416286	1	3	2	   0.971	0.076	CD81	0.01338				186845_[CD81_Immunodeficiency,common_variable,6,613496]
chr11	2417089	2417954	3	4	2	   0.865	0.261	CD81	0.04596				186845_[CD81_Immunodeficiency,common_variable,6,613496]
chr11	6637536	6639017	1	4	5	   1.481	0.115	TPP1	0.00096				607998_[TPP1_Ceroid_lipofuscinosis,neuronal,2,204500/Spinocerebellar_ataxia,autosomal_recessive_7,609270]
chr11	9867102	9867297	3	3	1	   0.195	0.096	SBF2	0.00922			SBF2	607697_[SBF2_Charcot-Marie-Tooth_disease,type_4B2,604563]
chr11	17406786	17414685	3	3	2	   7.899	0.070	KCNJ11,ABCC8	0.00744			KCNJ11,ABCC8	600937_[KCNJ11_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17415803	17416832	1	7	2	   1.029	0.076	ABCC8	0.00231			ABCC8	600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17450102	17464439	1	6	3	  14.337	0.096	ABCC8	0.03504			ABCC8	600937_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,2,601820/Diabetes,permanent_neonatal,with_or_without_neurologic_features,606176/Diabetes_mellitus,type_2,susceptibility_to,125853/Diabetes_mellitus,transient_neonatal,3,610582/Maturity-onset_diabetes_of_the_young,type_13,616329],600509_[ABCC8_Hyperinsulinemic_hypoglycemia,familial,1,256450/Hypoglycemia_of_infancy,leucine-sensitive,240800/Diabetes_mellitus,transient_neonatal_2,610374/Diabetes_mellitus,noninsulin-dependent,125853/Diabetes_mellitus,permanent_neonatal,606176]
chr11	17519699	17522707	3	5	2	   3.008	0.057	USH1C	0.00177			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	17538938	17539031	1	3	1	   0.093	0.083	USH1C	0.00803			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	17552691	17552849	1	5	1	   0.158	0.102	USH1C	0.00252			USH1C	605242_[USH1C_Usher_syndrome,type_1C,276904/Deafness,autosomal_recessive_18A,602092]
chr11	22294320	22296303	1	4	2	   1.983	0.166	ANO5	0.04493				608662_[ANO5_Gnathodiaphyseal_dysplasia,166260/Muscular_dystrophy,limb-girdle,autosomal_recessive_12,611307/Miyoshi_muscular_dystrophy_3,613319]
chr11	31822229	31822414	3	5	1	   0.185	0.089	PAX6	0.00294			PAX6	607108_[PAX6_Aniridia,106210/Cataract_with_late-onset_corneal_dystrophy,106210/Anterior_segment_dysgenesis_5,multiple_subtypes,604229/Foveal_hypoplasia_1,136520/Keratitis,148190/Optic_nerve_hypoplasia,165550/Morning_glory_disc_anomaly,120430/Coloboma_of_optic_nerve,120430/Coloboma,ocular,120200],606985_[PAX6_Aniridia_2,617141]
chr11	32417793	32417963	3	4	1	   0.170	0.083	WT1	0.00397			WT1	607102_[WT1_Wilms_tumor,type_1,194070/Denys-Drash_syndrome,194080/Nephrotic_syndrome,type_4,256370/Frasier_syndrome,136680/Meacham_syndrome,608978/Mesothelioma,somatic,156240]
chr11	33743915	34938372	3	4	2	1194.457	0.076	CD59,APIP,PDHX	0.00346	yes	yes		107271_[CD59_Hemolytic_anemia,CD59-mediated,with_or_without_immune-mediated_polyneuropathy,612300],180385_[LMO2_Leukemia,acute_T-cell],115500_[CAT_Acatalasemia,614097],608769_[PDHX_Lacticacidemia_due_to_PDX1_deficiency,245349]
chr11	36589553	36589682	3	4	1	   0.129	0.108	RAG1	0.00729				179615_[RAG1_Severe_combined_immunodeficiency,B_cell-negative,601457/Omenn_syndrome,603554/Alpha/beta_T-cell_lymphopenia_with_gamma/delta_T-cell_expansion,severe_cytomegalovirus_infection,and_autoimmunity,609889/Combined_cellular_and_humoral_immune_defects_with_granulomas,233650]
chr11	45935360	45937397	3	4	6	   2.037	0.083	PEX16	0.09304				603360_[PEX16_Peroxisome_biogenesis_disorder_8A_(Zellweger),614876/Peroxisome_biogenesis_disorder_8B,614877]
chr11	61165236	61165457	1	6	1	   0.221	0.140	TMEM216	0.00179				613277_[TMEM216_Joubert_syndrome_2,608091/Meckel_syndrome_2,603194]
chr11	62457724	62458003	1	3	1	   0.279	0.108	BSCL2,HNRNPUL2-BSCL2	0.01082				606158_[BSCL2_Lipodystrophy,congenital_generalized,type_2,269700/Silver_spastic_paraplegia_syndrome,270685/Neuropathy,distal_hereditary_motor,type_VA,600794/Encephalopathy,progressive,with_or_without_lipodystrophy,615924]
chr11	62460125	62460279	1	4	1	   0.154	0.076	BSCL2,HNRNPUL2-BSCL2	0.00294				606158_[BSCL2_Lipodystrophy,congenital_generalized,type_2,269700/Silver_spastic_paraplegia_syndrome,270685/Neuropathy,distal_hereditary_motor,type_VA,600794/Encephalopathy,progressive,with_or_without_lipodystrophy,615924]
chr11	65638618	65639842	3	3	2	   1.224	0.102	EFEMP2	0.00497				604633_[EFEMP2_Cutis_laxa,autosomal_recessive,type_IB,614437]
chr11	66298355	66298509	3	7	1	   0.154	0.121	BBS1,ZDHHC24	0.00045				209901_[BBS1_Bardet-Biedl_syndrome_1,209900]
chr11	66459997	66460581	1	3	2	   0.584	0.108	SPTBN2	0.00916				604985_[SPTBN2_Spinocerebellar_ataxia_5,600224/Spinocerebellar_ataxia,autosomal_recessive_14,615386]
chr11	66617072	66617340	3	6	1	   0.268	0.057	PC	0.00170				608786_[PC_Pyruvate_carboxylase_deficiency,266150]
chr11	66638513	66638961	1	4	2	   0.448	0.070	PC	0.00373				608786_[PC_Pyruvate_carboxylase_deficiency,266150]
chr11	67374313	67375959	3	5	2	   1.646	0.089	NDUFV1	0.00299			NDUFV1	161015_[NDUFV1_Mitochondrial_complex_I_deficiency,nuclear_type_4,618225]
chr11	67765136	67765932	3	5	2	   0.796	0.108	UNC93B1	0.00693				608204_[UNC93B1_Encephalopathy,acute,infection-induced_(herpes-specific),susceptibility_to,1,610551]
chr11	67816336	67817731	3	4	4	   1.395	0.153	TCIRG1	0.09107				604592_[TCIRG1_Osteopetrosis,autosomal_recessive_1,259700]
chr11	68115305	68157530	3	9	5	  42.225	0.057	LRP5	0.01002				603506_[LRP5_Osteoporosis-pseudoglioma_syndrome,259770/Bone_mineral_density_variability_1,601884/Hyperostosis,endosteal,144750/van_Buchem_disease,type_2,607636/Osteosclerosis,144750/Osteoporosis,166710/Exudative_vitreoretinopathy_4,601813/Osteopetrosis,autosomal_dominant_1,607634/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875]
chr11	68193436	68193665	3	3	1	   0.229	0.051	LRP5	0.00922				603506_[LRP5_Osteoporosis-pseudoglioma_syndrome,259770/Bone_mineral_density_variability_1,601884/Hyperostosis,endosteal,144750/van_Buchem_disease,type_2,607636/Osteosclerosis,144750/Osteoporosis,166710/Exudative_vitreoretinopathy_4,601813/Osteopetrosis,autosomal_dominant_1,607634/Polycystic_liver_disease_4_with_or_without_kidney_cysts,617875]
chr11	68549229	68549437	3	5	1	   0.208	0.045	CPT1A	0.00201				600528_[CPT1A_CPT_deficiency,hepatic,type_IA,255120]
chr11	68574925	68575116	3	3	1	   0.191	0.096	CPT1A	0.00508				600528_[CPT1A_CPT_deficiency,hepatic,type_IA,255120]
chr11	68682281	68685361	1	5	2	   3.080	0.115	IGHMBP2	0.02048				600502_[IGHMBP2_Neuronopathy,distal_hereditary_motor,type_VI,604320/Charcot-Marie-Tooth_disease,axonal,type_2S,616155]
chr11	68702757	68702900	1	4	1	   0.143	0.076	IGHMBP2	0.00460				600502_[IGHMBP2_Neuronopathy,distal_hereditary_motor,type_VI,604320/Charcot-Marie-Tooth_disease,axonal,type_2S,616155]
chr11	70644538	70653286	3	7	2	   8.748	0.083	SHANK2	0.00165			SHANK2	603290_[SHANK2_Autism_susceptibility_17,613436]
chr11	71152263	71153409	3	8	2	   1.146	0.089	DHCR7	0.00007			DHCR7	602858_[DHCR7_Smith-Lemli-Opitz_syndrome,270400]
chr11	76839300	76839545	3	4	1	   0.245	0.121	MYO7A	0.00475				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76867696	76867837	3	3	1	   0.141	0.076	MYO7A	0.01090				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76872009	76877218	3	8	3	   5.209	0.089	MYO7A	0.01541				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76892987	76894212	3	4	3	   1.225	0.115	MYO7A	0.00498				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	76909530	76910873	3	5	2	   1.343	0.083	MYO7A	0.00170				276903_[MYO7A_Usher_syndrome,type_1B,276900/Deafness,autosomal_recessive_2,600060/Deafness,autosomal_dominant_11,601317]
chr11	86748876	86749238	3	4	1	   0.362	0.185	TMEM135	0.00899				
chr11	94180375	94180614	3	6	1	   0.239	0.083	MRE11	0.00093				600814_[MRE11_Ataxia-telangiectasia-like_disorder_1,604391]
chr11	103052476	103052625	1	4	1	   0.149	0.121	DYNC2H1	0.00814				603297_[DYNC2H1_Short-rib_thoracic_dysplasia_3_with_or_without_polydactyly,613091]
chr11	108014700	108014784	1	5	1	   0.084	0.089	ACAT1	0.00222				607809_[ACAT1_Alpha-methylacetoacetic_aciduria,203750]
chr11	108175392	108175589	1	4	1	   0.197	0.102	ATM	0.00934				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	108178614	108178721	3	3	1	   0.107	0.127	ATM	0.01675				607585_[ATM_Ataxia-telangiectasia,208900/Lymphoma,B-cell_non-Hodgkin,somatic/Breast_cancer,susceptibility_to,114480/Lymphoma,mantle_cell,somatic/T-cell_prolymphocytic_leukemia,somatic]
chr11	111739315	111741103	1	3	2	   1.788	0.127	ALG9	0.03749				606941_[ALG9_Congenital_disorder_of_glycosylation,type_Il,608776/Gillessen-Kaesbach-Nishimura_syndrome,263210]
chr11	118895891	118896049	1	4	1	   0.158	0.146	SLC37A4,TRAPPC4	0.00699				602671_[SLC37A4_Glycogen_storage_disease_Ib,232220/Glycogen_storage_disease_Ic,232240]
chr11	126293386	126294928	3	4	1	   1.542	0.032	KIRREL3	0.00309				
chr11	126306696	126315010	3	10	2	   8.314	0.108	KIRREL3	0.00093				
chr12	406197	406376	1	4	1	   0.179	0.064	KDM5A	0.00639				
chr12	971239	971446	3	7	1	   0.207	0.089	WNK1	0.00045				605232_[WNK1_Pseudohypoaldosteronism,type_IIC,614492/Neuropathy,hereditary_sensory_and_autonomic,type_II,201300]
chr12	5019063	5019648	4	8	1	   0.585	0.140	KCNA1	0.00019			KCNA1	176260_[KCNA1_Episodic_ataxia/myokymia_syndrome,160120]
chr12	7044700	7046734	4	4	1	   2.034	0.159	ATN1	0.00301				607462_[ATN1_Dentatorubro-pallidoluysian_atrophy,125370]
chr12	7054924	7168191	1	3	2	 113.267	0.127	C12ORF57,C1S	0.03896				615140_[C12ORF57_Temtamy_syndrome,218340],611531_[EMG1_Bowen-Conradi_syndrome,211180],120580_[C1S_C1s_deficiency,613783/Ehlers-Danlos_syndrome,periodontal_type,2,617174]
chr12	7241879	7242339	1	3	2	   0.460	0.102	C1R	0.02742				613785_[C1R_Ehlers-Danlos_syndrome,periodontal_type,1,130080]
chr12	7361591	7361776	3	4	1	   0.185	0.121	PEX5	0.00361				600414_[PEX5_Peroxisome_biogenesis_disorder_2A_(Zellweger),214110/Peroxisome_biogenesis_disorder_2B,202370/Rhizomelic_chondrodysplasia_punctata,type_5,616716]
chr12	13722754	13722961	1	4	1	   0.207	0.134	GRIN2B	0.00601			GRIN2B	138252_[GRIN2B_Mental_retardation,autosomal_dominant_6,613970/Epileptic_encephalopathy,early_infantile,27,616139]
chr12	31237893	31238070	1	4	1	   0.177	0.102	DDX11	0.00341	yes			601150_[DDX11_Warsaw_breakage_syndrome,613398]
chr12	41331362	41331499	3	6	1	   0.137	0.089	CNTN1	0.00226				600016_[CNTN1_Myopathy,congenital,Compton-North,612540]
chr12	41410474	41410728	3	4	1	   0.254	0.070	CNTN1	0.00720				600016_[CNTN1_Myopathy,congenital,Compton-North,612540]
chr12	49428183	49428269	1	5	1	   0.086	0.076	KMT2D	0.00196			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49433497	49435328	3	5	1	   1.831	0.051	KMT2D	0.00092			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49435862	49436438	1	4	2	   0.576	0.102	KMT2D	0.01541			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49436849	49436979	1	4	1	   0.130	0.146	KMT2D	0.00484			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49437973	49438315	1	2	2	   0.342	0.070	KMT2D	0.00466			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	49448301	49448819	1	3	2	   0.518	0.140	KMT2D	0.01807			KMT2D	602113_[KMT2D_Kabuki_syndrome_1,147920]
chr12	51130809	51130903	1	4	1	   0.094	0.096	DIP2B	0.00324				611379_[DIP2B_Mental_retardation,FRA12A_type,136630]
chr12	56091712	56091820	1	3	1	   0.108	0.051	ITGA7	0.00397				600536_[ITGA7_Muscular_dystrophy,congenital,due_to_ITGA7_deficiency,613204]
chr12	56092157	56092370	3	4	1	   0.213	0.178	ITGA7	0.00322				600536_[ITGA7_Muscular_dystrophy,congenital,due_to_ITGA7_deficiency,613204]
chr12	56101251	56101696	3	4	1	   0.445	0.134	ITGA7	0.00402				600536_[ITGA7_Muscular_dystrophy,congenital,due_to_ITGA7_deficiency,613204]
chr12	56473799	56477696	3	6	2	   3.897	0.083	ERBB3	0.00124				190151_[ERBB3_Lethal_congenital_contractural_syndrome_2,607598/Erythroleukemia,familial,susceptibility_to,133180]
chr12	57965834	57966519	3	6	2	   0.685	0.083	KIF5A	0.00092				602821_[KIF5A_Spastic_paraplegia_10,autosomal_dominant,604187/Myoclonus,intractable,neonatal,617235/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921]
chr12	57969413	57969550	1	3	1	   0.137	0.045	KIF5A	0.00656				602821_[KIF5A_Spastic_paraplegia_10,autosomal_dominant,604187/Myoclonus,intractable,neonatal,617235/Amyotrophic_lateral_sclerosis,susceptibility_to,25,617921]
chr12	58159070	58159292	1	5	1	   0.222	0.057	CYP27B1	0.00225				609506_[CYP27B1_Vitamin_D-dependent_rickets,type_I,264700]
chr12	65122726	65122847	3	3	1	   0.121	0.089	GNS	0.00574				607664_[GNS_Mucopolysaccharidosis_type_IIID,252940]
chr12	88476798	88477017	3	4	1	   0.219	0.076	CEP290	0.00667			CEP290	610142_[CEP290_Joubert_syndrome_5,610188/Senior-Loken_syndrome_6,610189/Leber_congenital_amaurosis_10,611755/Meckel_syndrome_4,611134/Bardet-Biedl_syndrome_14,615991]
chr12	106826086	106826268	3	3	1	   0.182	0.115	POLR3B	0.01095				614366_[POLR3B_Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381]
chr12	106897849	106898042	3	3	1	   0.193	0.102	POLR3B	0.00720				614366_[POLR3B_Leukodystrophy,hypomyelinating,8,with_or_without_oligodontia_and/or_hypogonadotropic_hypogonadism,614381]
chr12	110017597	110017761	1	3	1	   0.164	0.083	MVK	0.00427				251170_[MVK_Mevalonic_aciduria,610377/Hyper-IgD_syndrome,260920/Porokeratosis_3,multiple_types,175900]
chr12	110023817	110023940	3	4	1	   0.123	0.057	MVK	0.00556				251170_[MVK_Mevalonic_aciduria,610377/Hyper-IgD_syndrome,260920/Porokeratosis_3,multiple_types,175900]
chr12	110220882	110222252	3	16	2	   1.370	0.108	TRPV4	0.00002				605427_[TRPV4_Brachyolmia_type_3,113500/Spondylometaphyseal_dysplasia,Kozlowski_type,184252/Metatropic_dysplasia,156530/Hereditary_motor_and_sensory_neuropathy,type_IIc,606071/Scapuloperoneal_spinal_muscular_atrophy,181405/Sodium_serum_level_QTL_1,613508/Parastremmatic_dwarfism,168400/SED,Maroteaux_type,184095/Spinal_muscular_atrophy,distal,congenital_nonprogressive,600175/Digital_arthropathy-brachydactyly,familial,606835/Avascular_necrosis_of_femoral_head,primary,2,617383]
chr12	110231322	110232302	4	2	3	   0.980	0.146	TRPV4	0.01454				605427_[TRPV4_Brachyolmia_type_3,113500/Spondylometaphyseal_dysplasia,Kozlowski_type,184252/Metatropic_dysplasia,156530/Hereditary_motor_and_sensory_neuropathy,type_IIc,606071/Scapuloperoneal_spinal_muscular_atrophy,181405/Sodium_serum_level_QTL_1,613508/Parastremmatic_dwarfism,168400/SED,Maroteaux_type,184095/Spinal_muscular_atrophy,distal,congenital_nonprogressive,600175/Digital_arthropathy-brachydactyly,familial,606835/Avascular_necrosis_of_femoral_head,primary,2,617383]
chr12	110781027	110782786	1	3	2	   1.759	0.153	ATP2A2	0.04022				108740_[ATP2A2_Darier_disease,124200/Acrokeratosis_verruciformis,101900]
chr12	111893823	111908556	3	12	3	  14.733	0.076	ATXN2	0.00358				601517_[ATXN2_Spinocerebellar_ataxia_2,183090/Amyotrophic_lateral_sclerosis,susceptibility_to,13,183090/Parkinson_disease,late-onset,susceptibility_to,168600]
chr12	116457573	116457787	3	4	1	   0.214	0.045	MED13L	0.00402			MED13L	608771_[MED13L_Transposition_of_the_great_arteries,dextro-looped_1,608808/Mental_retardation_and_distinctive_facial_features_with_or_without_cardiac_defects,616789]
chr12	121437061	121437440	3	3	2	   0.379	0.070	HNF1A	0.02421				142410_[HNF1A_MODY,type_III,600496/Diabetes_mellitus,noninsulin-dependent,2,125853/Diabetes_mellitus,insulin-dependent,222100/Hepatic_adenoma,somatic,142330/Renal_cell_carcinoma,144700/Diabetes_mellitus,insulin-dependent,20,612520]
chr12	122763329	122763499	1	4	1	   0.170	0.096	CLIP1	0.00322				
chr12	122821169	122826254	1	5	2	   5.085	0.076	CLIP1	0.00322				
chr12	124236820	124236959	3	5	1	   0.139	0.127	ATP6V0A2	0.00309				611716_[ATP6V0A2_Cutis_laxa,autosomal_recessive,type_IIA,219200/Wrinkly_skin_syndrome,278250]
chr12	132425827	132426538	3	3	1	   0.711	0.083	PUS1	0.00689				608109_[PUS1_Myopathy,lactic_acidosis,and_sideroblastic_anemia_1,600462]
chr13	32652961	32691620	3	4	2	  38.659	0.070	FRY	0.00162				
chr13	32749673	32749779	3	4	1	   0.106	0.096	FRY	0.01206				
chr13	32760387	32760567	3	4	1	   0.180	0.083	FRY	0.00169				
chr13	32802583	32802801	1	3	1	   0.218	0.134	FRY	0.00756				
chr13	39422588	39425255	1	5	3	   2.667	0.083	FREM2	0.04606				608945_[FREM2_Fraser_syndrome_2,617666]
chr13	41379244	41379401	1	4	1	   0.157	0.032	SLC25A15	0.00264				603861_[SLC25A15_Hyperornithinemia-hyperammonemia-homocitrullinemia_syndrome,238970]
chr13	51528031	51528131	4	5	1	   0.100	0.204	RNASEH2B	0.00371				610326_[RNASEH2B_Aicardi-Goutieres_syndrome_2,610181]
chr13	52531642	52536059	3	9	4	   4.417	0.032	ATP7B	0.00151				606882_[ATP7B_Wilson_disease,277900]
chr13	100634016	100637373	3	3	2	   3.357	0.146	ZIC2	0.01180			ZIC2	603073_[ZIC2_Holoprosencephaly_5,609637]
chr13	100764237	100764325	1	3	1	   0.088	0.064	PCCA	0.00513				232000_[PCCA_Propionicacidemia,606054]
chr13	100925440	100925610	1	3	1	   0.170	0.064	PCCA	0.01003				232000_[PCCA_Propionicacidemia,606054]
chr13	102521065	102521188	3	5	1	   0.123	0.076	FGF14	0.00151				601515_[FGF14_Spinocerebellar_ataxia_27,609307]
chr13	103508392	103510778	3	5	2	   2.386	0.025	BIVM-ERCC5,ERCC5	0.02294				133530_[ERCC5_Xeroderma_pigmentosum,group_G,278780/Xeroderma_pigmentosum,group_G/Cockayne_syndrome,278780/Cerebrooculofacioskeletal_syndrome_3,616570]
chr13	110829222	110833746	1	3	4	   4.524	0.166	COL4A1	0.11818				120130_[COL4A1_Porencephaly_1,175780/Brain_small_vessel_disease_with_or_without_ocular_anomalies,607595/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773/Hemorrhage,intracerebral,susceptibility_to,614519/Retinal_arteries,tortuosity_of,180000/Schizencephaly,269160]
chr13	110847360	110847475	1	3	1	   0.115	0.134	COL4A1	0.01336				120130_[COL4A1_Porencephaly_1,175780/Brain_small_vessel_disease_with_or_without_ocular_anomalies,607595/Angiopathy,hereditary,with_nephropathy,aneurysms,and_muscle_cramps,611773/Hemorrhage,intracerebral,susceptibility_to,614519/Retinal_arteries,tortuosity_of,180000/Schizencephaly,269160]
chr13	111117742	111132747	1	6	4	  15.005	0.121	COL4A2	0.06216				120090_[COL4A2_Porencephaly_2,614483/Hemorrhage,intracerebral,susceptibility_to,614519]
chr14	20769982	20774163	3	5	2	   4.181	0.089	TTC5	0.00348				
chr14	23245032	23245155	1	5	1	   0.123	0.134	SLC7A7	0.00117				603593_[SLC7A7_Lysinuric_protein_intolerance,222700]
chr14	23888376	23888514	1	3	1	   0.138	0.115	MYH7	0.01059				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	23893106	23894243	3	3	2	   1.137	0.057	MYH7	0.00839				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	23896784	23897889	3	3	2	   1.105	0.096	MYH7	0.04066				160760_[MYH7_Cardiomyopathy,hypertrophic,1,192600/Cardiomyopathy,dilated,1S,613426/Myopathy,myosin_storage,autosomal_dominant,608358/Laing_distal_myopathy,160500/Scapuloperoneal_syndrome,myopathic_type,181430/Left_ventricular_noncompaction_5,613426/Myopathy,myosin_storage,autosomal_recessive,255160]
chr14	24727731	24727889	3	5	1	   0.158	0.153	TGM1	0.00645				190195_[TGM1_Ichthyosis,congenital,autosomal_recessive_1,242300]
chr14	32030581	32031431	1	3	2	   0.850	0.210	NUBPL	0.13065				613621_[NUBPL_Mitochondrial_complex_I_deficiency,nuclear_type_21,618242]
chr14	45650830	45653115	1	3	2	   2.285	0.051	FANCM	0.00509				609644_[FANCM_Spermatogenic_failure_28,618086/Premature_ovarian_failure_15,618096]
chr14	51081081	51081239	3	3	1	   0.158	0.019	ATL1	0.00953				606439_[ATL1_Spastic_paraplegia_3A,autosomal_dominant,182600/Neuropathy,hereditary_sensory,type_ID,613708]
chr14	64494192	64496787	1	4	2	   2.595	0.076	SYNE2	0.02320				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999]
chr14	64532140	64532378	3	4	1	   0.238	0.115	SYNE2	0.00180				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999]
chr14	64644066	64644211	1	4	1	   0.145	0.096	ESR2,SYNE2	0.00756				608442_[SYNE2_Emery-Dreifuss_muscular_dystrophy_5,autosomal_dominant,612999],601663_[ESR2_Ovarian_dysgenesis_8,618187]
chr14	66974115	66975319	3	4	1	   1.204	0.134	GPHN	0.00328			GPHN	603930_[GPHN_Molybdenum_cofactor_deficiency_C,615501]
chr14	67431898	67432052	1	4	1	   0.154	0.083	GPHN	0.00484			GPHN	603930_[GPHN_Molybdenum_cofactor_deficiency_C,615501]
chr14	68222655	68228311	3	4	2	   5.656	0.076	ZFYVE26	0.00918				612012_[ZFYVE26_Spastic_paraplegia_15,autosomal_recessive,270700]
chr14	68249487	68250252	1	4	1	   0.765	0.096	ZFYVE26	0.00484				612012_[ZFYVE26_Spastic_paraplegia_15,autosomal_recessive,270700]
chr14	74947395	74951300	3	6	2	   3.905	0.051	NPC2	0.00115				601015_[NPC2_Niemann-pick_disease,type_C2,607625]
chr14	77741289	77744861	1	7	2	   3.572	0.051	POMT2	0.00073				607439_[POMT2_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158]
chr14	77745062	77746281	3	3	2	   1.219	0.096	POMT2	0.04099				607439_[POMT2_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,2,613150/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,2,613156/Muscular_dystrophy-dystroglycanopathy_(limb-girdle),type_C,2,613158]
chr14	77919632	77919754	3	4	1	   0.122	0.076	VIPAS39	0.00475				613401_[VIPAS39_Arthrogryposis,renal_dysfunction,and_cholestasis_2,613404]
chr14	78021633	78028842	1	6	3	   7.209	0.102	SPTLC2	0.01702				605713_[SPTLC2_Neuropathy,hereditary_sensory_and_autonomic,type_IC,613640]
chr14	81558865	81558962	3	4	1	   0.097	0.178	TSHR	0.00685				603372_[TSHR_Hypothyroidism,congenital,nongoitrous,1_275200/Thyroid_adenoma,hyperfunctioning,somatic/Hyperthyroidism,nonautoimmune,609152/Thyroid_carcinoma_with_thyrotoxicosis/Hyperthyroidism,familial_gestational,603373]
chr14	90499440	90499568	1	4	1	   0.128	0.140	TDP1	0.01541				607198_[TDP1_Spinocerebellar_ataxia,autosomal_recessive_with_axonal_neuropathy,607250]
chr15	25200125	25200219	3	5	1	   0.094	0.134	SNRPN,SNURF	0.00245			SNRPN,SNURF	182279_[SNRPN_Prader-Willi_syndrome,176270]
chr15	25221442	25223475	1	3	4	   2.033	0.134	SNRPN,SNURF	0.05350			SNRPN,SNURF	182279_[SNRPN_Prader-Willi_syndrome,176270]
chr15	34629523	40698182	3	3	2	6068.659	0.134	SLC12A6,IVD	0.02221	yes	yes	GJD2,MEIS2,SPRED1	604878_[SLC12A6_Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy,218000],606471_[NOP10_Dyskeratosis_congenita,autosomal_recessive_1,224230],102540_[ACTC1_Cardiomyopathy,dilated,1R,613424/Cardiomyopathy,hypertrophic,11,612098/Atrial_septal_defect_5,612794/Left_ventricular_noncompaction_4,613424],615626_[C15ORF41_Dyserythropoietic_anemia,congenital,type_Ib,615631],601740_[MEIS2_Cleft_palate,cardiac_defects,and_mental_retardation,600987],609291_[SPRED1_Legius_syndrome,611431],609280_[EIF2AK4_Pulmonary_venoocclusive_disease_2,234810],602860_[BUB1B_Colorectal_cancer,somatic,114500/Mosaic_variegated_aneuploidy_syndrome_1,257300/Premature_chromatid_separation_trait,176430],604114_[PLCB2_Platelet_PLC_beta-2_deficiency],607036_[IVD_Isovaleric_acidemia,243500]
chr15	40703449	40703562	1	4	1	   0.113	0.045	IVD	0.00294				607036_[IVD_Isovaleric_acidemia,243500]
chr15	42676671	42681304	3	5	4	   4.633	0.038	CAPN3	0.00617				114240_[CAPN3_Muscular_dystrophy,limb-girdle,autosomal_recessive_1,253600/Muscular_dystrophy,limb-girdle,autosomal_dominant_4,618129]
chr15	42696967	42697163	3	4	1	   0.196	0.127	CAPN3	0.00427				114240_[CAPN3_Muscular_dystrophy,limb-girdle,autosomal_recessive_1,253600/Muscular_dystrophy,limb-girdle,autosomal_dominant_4,618129]
chr15	43322132	43328487	1	3	2	   6.355	0.057	UBR1	0.01100			UBR1	605981_[UBR1_Johanson-Blizzard_syndrome,243800]
chr15	43346930	43347107	3	3	1	   0.177	0.076	UBR1	0.01132			UBR1	605981_[UBR1_Johanson-Blizzard_syndrome,243800]
chr15	44881440	44881622	1	6	1	   0.182	0.115	SPG11	0.00186				610844_[SPG11_Spastic_paraplegia_11,autosomal_recessive,604360/Amyotrophic_lateral_sclerosis_5,juvenile,602099/Charcot-Marie-Tooth_disease,axonal,type_2X,616668]
chr15	45392238	45393046	1	3	2	   0.808	0.127	DUOX2	0.07439				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	45405175	45405280	1	3	1	   0.105	0.146	DUOX2	0.00731				606759_[DUOX2_Thyroid_dyshormonogenesis_6,607200]
chr15	48533702	48533806	3	7	1	   0.104	0.045	SLC12A1	0.00050			SLC12A1	600839_[SLC12A1_Bartter_syndrome,type_1,601678]
chr15	48541762	48541883	3	3	1	   0.121	0.064	SLC12A1	0.00373			SLC12A1	600839_[SLC12A1_Bartter_syndrome,type_1,601678]
chr15	48591327	48591482	1	4	1	   0.155	0.127	SLC12A1	0.00922			SLC12A1	600839_[SLC12A1_Bartter_syndrome,type_1,601678]
chr15	48780555	48780700	1	4	1	   0.145	0.083	FBN1	0.00642			FBN1	134797_[FBN1_Marfan_syndrome,154700/Marfan_lipodystrophy_syndrome,616914/Ectopia_lentis,familial,129600/MASS_syndrome,604308/Weill-Marchesani_syndrome_2,dominant,608328/Stiff_skin_syndrome,184900/Acromicric_dysplasia,102370/Geleophysic_dysplasia_2,614185]
chr15	74630902	74631119	3	4	1	   0.217	0.108	CYP11A1	0.00915				118485_[CYP11A1_Adrenal_insufficiency,congenital,with_46XY_sex_reversal,partial_or_complete,613743]
chr15	75184992	75185153	1	3	1	   0.161	0.127	MPI	0.01159				154550_[MPI_Congenital_disorder_of_glycosylation,type_Ib,602579]
chr15	77092579	77154295	1	6	6	  61.716	0.089	SCAPER	0.09773				611611_[SCAPER_Intellectual_developmental_disorder_and_retinitis_pigmentosa,618195]
chr15	89807743	89811766	3	4	2	   4.023	0.057	FANCI	0.00540				611360_[FANCI_Fanconi_anemia,complementation_group_I,609053]
chr15	89849228	89849435	1	3	1	   0.207	0.032	FANCI	0.00376				611360_[FANCI_Fanconi_anemia,complementation_group_I,609053]
chr15	89865963	89866752	1	2	2	   0.789	0.108	POLG	0.00466				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	89868671	89869979	3	7	2	   1.308	0.076	POLG	0.00290				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	89870388	89872351	1	6	4	   1.963	0.025	POLG	0.00373				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	89876317	89877154	3	3	1	   0.837	0.083	POLG	0.00731				174763_[POLG_Progressive_external_ophthalmoplegia,autosomal_recessive_1,258450/Progressive_external_ophthalmoplegia,autosomal_dominant_1,157640/Mitochondrial_DNA_depletion_syndrome_4B_(MNGIE_type),613662/Mitochondrial_DNA_depletion_syndrome_4A_(Alpers_type),203700/Mitochondrial_recessive_ataxia_syndrome_(includes_SANDO_and_SCAE),607459]
chr15	90174716	90188406	1	3	5	  13.690	0.089	KIF7	0.07870				611254_[KIF7_Hydrolethalus_syndrome_2,614120/Acrocallosal_syndrome,200990/Joubert_syndrome_12,200990/Al-Gazali-Bakalinova_syndrome,607131]
chr15	90192195	90193182	3	6	2	   0.987	0.121	KIF7	0.00143				611254_[KIF7_Hydrolethalus_syndrome_2,614120/Acrocallosal_syndrome,200990/Joubert_syndrome_12,200990/Al-Gazali-Bakalinova_syndrome,607131]
chr15	91312658	91328321	1	4	2	  15.663	0.191	BLM	0.05651				604610_[BLM_Bloom_syndrome,210900]
chr15	91551090	91551204	1	3	1	   0.114	0.229	VPS33B	0.00834				608552_[VPS33B_Arthrogryposis,renal_dysfunction,and_cholestasis_1,208085]
chr15	91557024	91560264	3	4	2	   3.240	0.064	VPS33B	0.02658				608552_[VPS33B_Arthrogryposis,renal_dysfunction,and_cholestasis_1,208085]
chr16	1248605	1252462	3	13	4	   3.857	0.268	CACNA1H	0.00404			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1260777	1263941	3	2	6	   3.164	0.242	CACNA1H	0.18579			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1268200	1269140	3	3	2	   0.940	0.159	CACNA1H	0.05672			CACNA1H	607904_[CACNA1H_Epilepsy,idiopathic_generalized,susceptibility_to,6,611942/Epilepsy,childhood_absence,susceptibility_to,6,611942/Hyperaldosteronism,familial,type_IV,617027]
chr16	1496997	1497579	3	4	2	   0.582	0.108	CLCN7	0.00756				602727_[CLCN7_Osteopetrosis,autosomal_recessive_4,611490/Osteopetrosis,autosomal_dominant_2,166600]
chr16	2105393	2106780	3	5	2	   1.387	0.146	TSC2	0.03798			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2112488	2112611	1	4	1	   0.123	0.096	TSC2	0.00471			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2131586	2131809	1	5	1	   0.223	0.102	TSC2	0.00231			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2133686	2133827	3	5	1	   0.141	0.108	TSC2	0.00231			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2137854	2138150	3	2	2	   0.296	0.223	TSC2	0.06824			TSC2	191092_[TSC2_Tuberous_sclerosis-2,613254/Lymphangioleiomyomatosis,somatic,606690/Focal_cortical_dysplasia,type_II,somatic,607341]
chr16	2155313	2155485	4	4	1	   0.172	0.159	PKD1	0.00376	yes		PKD1	601313_[PKD1_Polycystic_kidney_disease_1,173900]
chr16	2328934	2329141	1	4	1	   0.207	0.064	ABCA3	0.00346				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	2333177	2333369	3	4	1	   0.192	0.121	ABCA3	0.00422				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	2367274	2369851	3	4	3	   2.577	0.083	ABCA3	0.01065				601615_[ABCA3_Surfactant_metabolism_dysfunction,pulmonary,3,610921]
chr16	3781767	3786214	3	4	2	   4.447	0.255	CREBBP	0.03395			CREBBP	600140_[CREBBP_Rubinstein-Taybi_syndrome_1,180849]
chr16	3828691	3830889	3	3	2	   2.198	0.051	CREBBP	0.00374			CREBBP	600140_[CREBBP_Rubinstein-Taybi_syndrome_1,180849]
chr16	5130937	5132684	3	4	2	   1.747	0.076	ALG1	0.00919				605907_[ALG1_Congenital_disorder_of_glycosylation,type_Ik,608540]
chr16	10273845	10276273	3	3	2	   2.428	0.089	GRIN2A	0.00996			GRIN2A	138253_[GRIN2A_Epilepsy,focal,with_speech_disorder_and_with_or_without_mental_retardation,245570]
chr16	11002876	11003054	3	5	1	   0.178	0.115	CIITA	0.00105				600005_[CIITA_Bare_lymphocyte_syndrome,type_II,complementation_group_A,209920/Rheumatoid_arthritis,susceptibility_to,180300]
chr16	23430011	23436278	1	3	2	   6.267	0.096	COG7	0.00872				606978_[COG7_Congenital_disorder_of_glycosylation,type_IIe,608779]
chr16	23445947	23446049	3	3	1	   0.102	0.159	COG7	0.00756				606978_[COG7_Congenital_disorder_of_glycosylation,type_IIe,608779]
chr16	23635320	23637728	3	5	2	   2.408	0.070	PALB2	0.01363				610355_[PALB2_Fanconi_anemia,complementation_group_N,610832/Breast_cancer,susceptibility_to,114480/Pancreatic_cancer,susceptibility_to,3,613348]
chr16	28499902	28500717	3	3	2	   0.815	0.038	CLN3	0.00610				607042_[CLN3_Ceroid_lipofuscinosis,neuronal,3,204200]
chr16	28943250	28943419	3	5	1	   0.169	0.076	CD19	0.00173				107265_[CD19_Immunodeficiency,common_variable,3,613493]
chr16	30081141	30081360	1	4	1	   0.219	0.070	ALDOA	0.00374			ALDOA	103850_[ALDOA_Glycogen_storage_disease_XII,611881]
chr16	30081428	30195674	3	3	3	 114.246	0.083	ALDOA,CORO1A	0.06449	yes		ALDOA,TBX6	103850_[ALDOA_Glycogen_storage_disease_XII,611881],602427_[TBX6_Spondylocostal_dysostosis_5,122600],605000_[CORO1A_Immunodeficiency_8,615401]
chr16	31195169	31195333	1	4	1	   0.164	0.096	FUS	0.00697				137070_[FUS_Amyotrophic_lateral_sclerosis_6,with_or_without_frontotemporal_dementia,608030/Essential_tremor,hereditary,4,614782]
chr16	53675187	53675397	1	5	1	   0.210	0.115	RPGRIP1L	0.00484				610937_[RPGRIP1L_Joubert_syndrome_7,611560/Meckel_syndrome_5,611561/COACH_syndrome,216360]
chr16	53690374	53690511	3	3	1	   0.137	0.108	RPGRIP1L	0.01065				610937_[RPGRIP1L_Joubert_syndrome_7,611560/Meckel_syndrome_5,611561/COACH_syndrome,216360]
chr16	56544761	56544843	3	5	1	   0.082	0.083	BBS2	0.00404				606151_[BBS2_Bardet-Biedl_syndrome_2,615981/Retinitis_pigmentosa_74,616562]
chr16	56553648	56554018	4	6	1	   0.370	0.178	BBS2	0.00081				606151_[BBS2_Bardet-Biedl_syndrome_2,615981/Retinitis_pigmentosa_74,616562]
chr16	66503495	66511623	3	4	2	   8.128	0.102	BEAN1	0.01746				612051_[BEAN1_Spinocerebellar_ataxia_31,117210]
chr16	70310859	70311067	3	4	1	   0.208	0.089	AARS	0.00682				601065_[AARS_Charcot-Marie-Tooth_disease,axonal,type_2N,613287/Epileptic_encephalopathy,early_infantile,29,616339]
chr16	81397389	81397558	3	5	1	   0.169	0.140	GAN	0.00256				605379_[GAN_Giant_axonal_neuropathy-1,256850]
chr16	89811357	89813106	1	4	2	   1.749	0.051	FANCA	0.00731	yes		FANCA	607139_[FANCA_Fanconi_anemia,complementation_group_A,227650]
chr17	1264376	2541624	1	3	5	1277.248	0.057	YWHAE,PAFAH1B1	0.08773	yes	yes	YWHAE,PAFAH1B1	607875_[INPP5K_Muscular_dystrophy,congenital,with_cataracts_and_intellectual_disability,617404],607300_[PRPF8_Retinitis_pigmentosa_13,600059],614218_[WDR81_Cerebellar_ataxia,mental_retardation,and_dysequilibrium_syndrome_2,610185/Hydrocephalus,congenital,3,with_brain_anomalies,617967],613168_[SERPINF2_Alpha-2-plasmin_inhibitor_deficiency,262850],172860_[SERPINF1_Osteogenesis_imperfecta,type_VI,613982],603527_[DPH1_Developmental_delay_with_short_stature,dysmorphic_features,and_sparse_hair,616901],247200_[PAFAH1B1_Miller-Dieker_lissencephaly_syndrome],601545_[PAFAH1B1_Lissencephaly_1,607432/Subcortical_laminar_heterotopia,607432]
chr17	3402175	3540135	1	4	2	 137.960	0.032	ASPA,SPATA22,CTNS	0.00419			ASPA,CTNS	608034_[ASPA_Canavan_disease,271900],607066_[TRPV3_Olmsted_syndrome,614594/Palmoplantar_keratoderma,nonepidermolytic,focal_2,616400],605060_[SHPK_Sedoheptulokinase_deficiency,617213],606272_[CTNS_Cystinosis,nephropathic,219800/Cystinosis,ocular_nonnephropathic,219750/Cystinosis,late-onset_juvenile_or_adolescent_nephropathic,219900/Cystinosis,atypical_nephropathic,219800]
chr17	7351888	7357849	3	7	2	   5.961	0.096	CHRNB1	0.00094				100710_[CHRNB1_Myasthenic_syndrome,congenital,2A,slow-channel,616313/Myasthenic_syndrome,congenital,2C,associated_with_acetylcholine_receptor_deficiency,616314]
chr17	10436592	10436748	1	5	1	   0.156	0.096	MYH2	0.00428				160740_[MYH2_Proximal_myopathy_and_ophthalmoplegia,605637]
chr17	10446182	10446488	1	4	2	   0.306	0.025	MYH2	0.00314				160740_[MYH2_Proximal_myopathy_and_ophthalmoplegia,605637]
chr17	10542351	10542801	1	2	2	   0.450	0.064	MYH3	0.01240				160720_[MYH3_Arthrogryposis,distal,type_2A,193700/Arthrogryposis,distal,type_2B,601680/Arthrogryposis,distal,type_8,178110]
chr17	10596071	10596288	3	6	1	   0.217	0.051	SCO1	0.00108				603644_[SCO1_Mitochondrial_complex_IV_deficiency,220110]
chr17	15142778	15165899	3	15	4	  23.121	0.096	PMP22	0.00082			PMP22	601097_[PMP22_Charcot-Marie-Tooth_disease,type_1A,118220/Dejerine-Sottas_disease,145900/Neuropathy,recurrent,with_pressure_palsies,162500/Charcot-Marie-Tooth_disease,type_1E,118300/Roussy-Levy_syndrome,180800/Neuropathy,inflammatory_demyelinating,139393]
chr17	15928321	15928495	1	6	1	   0.174	0.096	TTC19	0.00294				613814_[TTC19_Mitochondrial_complex_III_deficiency,nuclear_type_2,615157]
chr17	17627332	17701837	3	8	2	  74.505	0.096	RAI1	0.00115			RAI1	607642_[RAI1_Smith-Magenis_syndrome,182290]
chr17	26861715	26862226	3	3	1	   0.511	0.153	FOXN1	0.00436				600838_[FOXN1_T-cell_immunodeficiency,congenital_alopecia,and_nail_dystrophy,601705]
chr17	29528045	29528513	1	3	2	   0.468	0.121	NF1	0.04301			NF1	613113_[NF1_Neurofibromatosis,type_1,162200/Leukemia,juvenile_myelomonocytic,607785/Neurofibromatosis,familial_spinal,162210/Neurofibromatosis-Noonan_syndrome,601321/Watson_syndrome,193520]
chr17	29579946	29580028	3	3	1	   0.082	0.051	NF1	0.00729			NF1	613113_[NF1_Neurofibromatosis,type_1,162200/Leukemia,juvenile_myelomonocytic,607785/Neurofibromatosis,familial_spinal,162210/Neurofibromatosis-Noonan_syndrome,601321/Watson_syndrome,193520]
chr17	40489443	40489885	1	4	2	   0.442	0.140	STAT3	0.00991	yes			102582_[STAT3_Hyper-IgE_recurrent_infection_syndrome,147060/Autoimmune_disease,multisystem,infantile-onset,1,615952]
chr17	42152038	42152148	1	4	1	   0.110	0.102	G6PC3	0.00490				611045_[G6PC3_Neutropenia,severe_congenital_4,autosomal_recessive,612541/Dursun_syndrome,612541]
chr17	42991386	42991466	1	3	1	   0.080	0.108	GFAP	0.00866				137780_[GFAP_Alexander_disease,203450]
chr17	44847139	44847424	3	5	1	   0.285	0.089	WNT3	0.00256				165330_[WNT3_Tetra-amelia_syndrome_1,273395]
chr17	48263668	48271412	3	27	13	   7.744	0.102	COL1A1	0.00060			COL1A1	120150_[COL1A1_Osteogenesis_imperfecta,type_I,166200/Osteogenesis_imperfecta,type_II,166210/Osteogenesis_imperfecta,type_III,259420/Caffey_disease,114000/Osteogenesis_imperfecta,type_IV,166220/Bone_mineral_density_variation_QTL,osteoporosis,166710/Ehlers-Danlos_syndrome,arthrochalasia_type,1,130060]
chr17	48650372	48653697	3	4	2	   3.325	0.089	CACNA1G	0.01065				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48673913	48680259	3	4	5	   6.346	0.236	CACNA1G	0.06948				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48681506	48685411	3	10	4	   3.905	0.121	CACNA1G	0.00704				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	48696006	48696379	3	3	1	   0.373	0.076	CACNA1G	0.00668				604065_[CACNA1G_Spinocerebellar_ataxia_42,616795/Spinocerebellar_ataxia_42,early-onset,severe,with_neurodevelopmental_deficits,618087]
chr17	59870948	59876670	3	6	2	   5.722	0.064	BRIP1	0.00309				605882_[BRIP1_Breast_cancer,early-onset,114480/Fanconi_anemia,complementation_group_J,609054]
chr17	61994553	61994876	3	3	1	   0.323	0.096	CSHL1,GH1	0.00339			GH1	139250_[GH1_Growth_hormone_deficiency,isolated,type_IA,262400/Growth_hormone_deficiency,isolated,type_IB,612781/Growth_hormone_deficiency,isolated,type_II,173100/Kowarski_syndrome,262650]
chr17	61996117	62006694	1	3	2	  10.577	0.057	CSHL1,GH1,CD79B	0.02029			GH1	139250_[GH1_Growth_hormone_deficiency,isolated,type_IA,262400/Growth_hormone_deficiency,isolated,type_IB,612781/Growth_hormone_deficiency,isolated,type_II,173100/Kowarski_syndrome,262650],147245_[CD79B_Agammaglobulinemia_6,612692]
chr17	62021096	62024537	3	6	4	   3.441	0.153	SCN4A	0.01042				603967_[SCN4A_Hyperkalemic_periodic_paralysis,type_2,170500/Paramyotonia_congenita,168300/Myotonia_congenita,atypical,acetazolamide-responsive,608390/Myasthenic_syndrome,congenital,16,614198/Hypokalemic_periodic_paralysis,type_2,613345]
chr17	62034512	62036808	3	11	2	   2.296	0.134	SCN4A	0.00083				603967_[SCN4A_Hyperkalemic_periodic_paralysis,type_2,170500/Paramyotonia_congenita,168300/Myotonia_congenita,atypical,acetazolamide-responsive,608390/Myasthenic_syndrome,congenital,16,614198/Hypokalemic_periodic_paralysis,type_2,613345]
chr17	72915539	72916776	3	4	1	   1.237	0.108	USH1G	0.00964				607696_[USH1G_Usher_syndrome,type_1G,606943]
chr17	73752500	73752708	3	3	1	   0.208	0.070	GALK1,ITGB4	0.00436				147557_[ITGB4_Epidermolysis_bullosa,junctional,with_pyloric_atresia,226730/Epidermolysis_bullosa,junctional,non-Herlitz_type,226650/Epidermolysis_bullosa_of_hands_and_feet,131800],604313_[GALK1_Galactokinase_deficiency_with_cataracts,230200]
chr17	73829037	73830807	1	4	3	   1.770	0.083	UNC13D	0.00374				608897_[UNC13D_Hemophagocytic_lymphohistiocytosis,familial,3,608898]
chr17	73832643	73833009	1	2	2	   0.366	0.134	UNC13D	0.00918				608897_[UNC13D_Hemophagocytic_lymphohistiocytosis,familial,3,608898]
chr17	73835910	73836201	3	2	2	   0.291	0.140	UNC13D	0.04161				608897_[UNC13D_Hemophagocytic_lymphohistiocytosis,familial,3,608898]
chr17	75483496	75486951	3	8	4	   3.455	0.096	SEPT9	0.01376	yes			604061_[SEPT9_Leukemia,acute_myeloid,therapy-related/Ovarian_carcinoma/Amyotrophy,hereditary_neuralgic,162100]
chr17	76109619	76109715	3	3	1	   0.096	0.115	TMC6	0.00693				605828_[TMC6_Epidermodysplasia_verruciformis,226400]
chr17	76120595	76120872	3	3	1	   0.277	0.210	TMC6	0.00667				605828_[TMC6_Epidermodysplasia_verruciformis,226400]
chr17	78079538	78079703	3	4	1	   0.165	0.038	GAA	0.00294				606800_[GAA_Glycogen_storage_disease_II,232300]
chr17	78085772	78085909	3	4	1	   0.137	0.153	GAA	0.00361				606800_[GAA_Glycogen_storage_disease_II,232300]
chr17	79478919	79479396	3	4	2	   0.477	0.210	ACTG1	0.01223				102560_[ACTG1_Deafness,autosomal_dominant_20/26,604717/Baraitser-Winter_syndrome_2,614583]
chr17	79894614	80038124	3	15	4	 143.510	0.121	PYCR1,FASN	0.00026	yes			179035_[PYCR1_Cutis_laxa,autosomal_recessive,type_IIB,612940/Cutis_laxa,autosomal_recessive,type_IIIB,614438],600864_[ASPSCR1_Advanced_sleep-phase_syndrome,familial,2,615224],606236_[ASPSCR1_Alveolar_soft-part_sarcoma,606243],608347_[DCXR_Pentosuria,260800]
chr17	80040189	80040564	1	3	2	   0.375	0.064	FASN	0.00513				
chr17	80045551	80045747	1	4	1	   0.196	0.115	FASN	0.00447				
chr17	80048241	80048450	1	4	1	   0.209	0.102	FASN	0.00693				
chr17	80051464	80051657	1	3	1	   0.193	0.102	FASN	0.00720				
chr18	6977716	6977890	1	3	1	   0.174	0.108	LAMA1	0.00751				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	6999434	6999647	1	4	1	   0.213	0.096	LAMA1	0.00535				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	7017267	7017393	3	6	1	   0.126	0.083	LAMA1	0.00105				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	7023153	7024475	1	5	2	   1.322	0.166	LAMA1	0.03222				150320_[LAMA1_Poretti-Boltshauser_syndrome,615960]
chr18	7080276	9117911	1	6	2	2037.635	0.083	LAMA1,NDUFV2	0.00904	yes	yes		150320_[LAMA1_Poretti-Boltshauser_syndrome,615960],600532_[NDUFV2_Mitochondrial_complex_I_deficiency,nuclear_type_7,618229]
chr18	21134712	21136587	3	7	2	   1.875	0.083	NPC1	0.00073				607623_[NPC1_Niemann-Pick_disease,type_C1,257220/Niemann-Pick_disease,type_D,257220]
chr18	21469965	21475032	1	3	2	   5.067	0.159	LAMA3	0.06327				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21479242	21483099	1	6	3	   3.857	0.121	LAMA3	0.17702				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	21531638	21531751	3	3	1	   0.113	0.083	LAMA3	0.00689				600805_[LAMA3_Epidermolysis_bullosa,junctional,Herlitz_type,226700/Epidermolysis_bullosa,generalized_atrophic_benign,226650/Laryngoonychocutaneous_syndrome,245660]
chr18	33718223	33718399	1	5	1	   0.176	0.089	ELP2	0.00346				616054_[ELP2_Mental_retardation,autosomal_recessive_58,617270]
chr18	42618440	42618630	3	6	1	   0.190	0.102	SETBP1	0.00162			SETBP1	611060_[SETBP1_Schinzel-Giedion_midface_retraction_syndrome,269150/Mental_retardation,autosomal_dominant_29,616078]
chr18	46812794	46858386	1	4	2	  45.592	0.096	DYM	0.03184			DYM	607461_[DYM_Dyggve-Melchior-Clausen_disease,223800/Smith-McCort_dysplasia,607326]
chr18	55371777	55371910	3	3	1	   0.133	0.140	ATP8B1	0.01641				602397_[ATP8B1_Cholestasis,progressive_familial_intrahepatic_1,211600/Cholestasis,benign_recurrent_intrahepatic,243300/Cholestasis,intrahepatic,of_pregnancy,1,147480]
chr18	77455967	77457998	3	5	2	   2.031	0.070	CTDP1	0.01130				604927_[CTDP1_Congenital_cataracts,facial_dysmorphism,and_neuropathy,604168]
chr18	77474481	77475538	3	4	1	   1.057	0.025	CTDP1	0.00591				604927_[CTDP1_Congenital_cataracts,facial_dysmorphism,and_neuropathy,604168]
chr19	863082	863620	3	5	1	   0.538	0.134	CFD	0.00339				134350_[CFD_Complement_factor_D_deficiency,613912]
chr19	3653278	3656565	3	6	2	   3.287	0.102	PIP5K1C	0.01050				606102_[PIP5K1C_Lethal_congenital_contractural_syndrome_3,611369]
chr19	6710988	6712644	3	5	3	   1.656	0.076	C3	0.02757			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	6719212	6719424	4	4	1	   0.212	0.191	C3	0.00839			C3	120700_[C3_C3_deficiency,613779/Hemolytic_uremic_syndrome,atypical,susceptibility_to,5,612925/Macular_degeneration,age-related,9,611378]
chr19	7122880	7123010	1	3	1	   0.130	0.045	INSR	0.00499		yes		147670_[INSR_Leprechaunism,246200/Rabson-Mendenhall_syndrome,262190/Diabetes_mellitus,insulin-resistant,with_acanthosis_nigricans,610549/Hyperinsulinemic_hypoglycemia,familial,5,609968]
chr19	7172291	7172455	3	3	1	   0.164	0.089	INSR	0.01109				147670_[INSR_Leprechaunism,246200/Rabson-Mendenhall_syndrome,262190/Diabetes_mellitus,insulin-resistant,with_acanthosis_nigricans,610549/Hyperinsulinemic_hypoglycemia,familial,5,609968]
chr19	7593473	7595397	3	5	5	   1.924	0.127	MCOLN1	0.08883				605248_[MCOLN1_Mucolipidosis_IV,252650]
chr19	7707305	7709648	3	7	4	   2.343	0.185	STXBP2	0.08125				601717_[STXBP2_Hemophagocytic_lymphohistiocytosis,familial,5,613101]
chr19	10246402	10247966	3	5	2	   1.564	0.038	DNMT1	0.00508				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10248498	10248695	1	3	1	   0.197	0.115	DNMT1	0.01050				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10251771	10251875	1	5	1	   0.104	0.089	DNMT1	0.00185				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10265252	10265459	1	3	1	   0.207	0.070	DNMT1	0.00919				126375_[DNMT1_Neuropathy,hereditary_sensory,type_IE,614116/Cerebellar_ataxia,deafness,and_narcolepsy,autosomal_dominant,604121]
chr19	10463592	10463784	3	3	1	   0.192	0.166	TYK2	0.01166				176941_[TYK2_Immunodeficiency_35,611521]
chr19	10467234	10467404	3	5	1	   0.170	0.102	TYK2	0.00231				176941_[TYK2_Immunodeficiency_35,611521]
chr19	10912954	10930775	3	4	3	  17.821	0.210	DNM2	0.05509				602378_[DNM2_Charcot-Marie-Tooth_disease,dominant_intermediate_B,606482/Centronuclear_myopathy_1,160150/Charcot-Marie-Tooth_disease,axonal_type_2M,606482/Lethal_congenital_contracture_syndrome_5,615368]
chr19	11096855	11097689	3	4	2	   0.834	0.089	SMARCA4	0.00346			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11123615	11129709	3	4	2	   6.094	0.191	SMARCA4	0.05672			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	11169454	11170571	3	4	2	   1.117	0.197	SMARCA4	0.00436			SMARCA4	603254_[SMARCA4_Rhabdoid_tumor_predisposition_syndrome_2,613325/Coffin-Siris_syndrome_4,614609]
chr19	12772064	12774286	3	4	2	   2.222	0.076	MAN2B1	0.00428				609458_[MAN2B1_Mannosidosis,alpha-,types_I_and_II,248500]
chr19	13218378	13220508	3	3	4	   2.130	0.089	TRMT1	0.06194				
chr19	13414571	13419075	3	7	3	   4.504	0.134	CACNA1A	0.00814			CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106]
chr19	13616736	14023261	3	11	3	 406.525	0.121	CACNA1A,CC2D1A	0.00196	yes	yes	CACNA1A	601011_[CACNA1A_Migraine,familial_hemiplegic,1,141500/Episodic_ataxia,type_2,108500/Spinocerebellar_ataxia_6,183086/Migraine,familial_hemiplegic,1,with_progressive_cerebellar_ataxia,141500/Epileptic_encephalopathy,early_infantile,42,617106],610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	14040182	14041703	3	3	4	   1.521	0.108	CC2D1A	0.03416				610055_[CC2D1A_Mental_retardation,autosomal_recessive_3,608443]
chr19	15290873	15291983	1	2	3	   1.110	0.070	NOTCH3	0.02192			NOTCH3	600276_[NOTCH3_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310/Myofibromatosis,infantile_2,615293/Lateral_meningocele_syndrome,130720]
chr19	15298682	15299169	1	3	2	   0.487	0.102	NOTCH3	0.03561			NOTCH3	600276_[NOTCH3_Cerebral_arteriopathy_with_subcortical_infarcts_and_leukoencephalopathy_1,125310/Myofibromatosis,infantile_2,615293/Lateral_meningocele_syndrome,130720]
chr19	17945370	17950482	1	9	8	   5.112	0.089	JAK3	0.00597				600173_[JAK3_SCID,autosomal_recessive,T-negative/B-positive_type,600802]
chr19	18170694	18170905	1	6	1	   0.211	0.064	IL12RB1	0.00222				601604_[IL12RB1_Immunodeficiency_30,614891]
chr19	18707692	18707869	3	4	1	   0.177	0.127	CRLF1	0.00290				604237_[CRLF1_Cold-induced_sweating_syndrome_1,272430]
chr19	34859478	34868501	3	5	2	   9.023	0.083	GPI	0.00458				172400_[GPI_Hemolytic_anemia,nonspherocytic,due_to_glucose_phosphate_isomerase_deficiency,613470]
chr19	36333016	36333462	1	3	2	   0.446	0.070	NPHS1	0.00374				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36339868	36340565	1	3	3	   0.697	0.057	NPHS1	0.00896				602716_[NPHS1_Nephrotic_syndrome,type_1,256300]
chr19	36583581	36590529	3	5	3	   6.948	0.070	WDR62	0.00113				613583_[WDR62_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317]
chr19	36595410	38931514	1	5	4	2336.104	0.115	WDR62,RYR1	0.01842	yes	yes		613583_[WDR62_Microcephaly_2,primary,autosomal_recessive,with_or_without_cortical_malformations,604317],616655_[SIPA1L3_Cataract_45,616851],605124_[SPINT2_Diarrhea_3,secretory_sodium,congenital,syndromic,270420],180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38932979	38934446	3	5	3	   1.467	0.127	RYR1	0.01519				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38955269	38955372	3	4	1	   0.103	0.108	RYR1	0.00527				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38976220	38980093	3	7	2	   3.873	0.140	RYR1	0.00422				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	38995939	38996048	1	4	1	   0.109	0.102	RYR1	0.00720				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39002702	39002782	1	9	1	   0.080	0.051	RYR1	0.00019				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39006717	39006867	1	3	1	   0.150	0.089	RYR1	0.00834				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39028510	39034085	3	4	2	   5.575	0.255	RYR1	0.04567				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	39071000	39071154	3	3	1	   0.154	0.242	RYR1	0.00786				180901_[RYR1_Malignant_hyperthermia_susceptibility_1,145600/Central_core_disease,117000/Minicore_myopathy_with_external_ophthalmoplegia,255320/Neuromuscular_disease,congenital,with_uniform_type_1_fiber,117000/King-Denborough_syndrome,145600]
chr19	41928059	41928285	3	3	1	   0.226	0.038	BCKDHA	0.00540				608348_[BCKDHA_Maple_syrup_urine_disease,type_Ia,248600]
chr19	45857978	45867179	3	8	8	   9.201	0.076	ERCC2	0.06864				126340_[ERCC2_Xeroderma_pigmentosum,group_D,278730/Trichothiodystrophy_1,photosensitive,601675/Cerebrooculofacioskeletal_syndrome_2,610756]
chr19	46281741	46282790	3	4	3	   1.049	0.032	DMPK	0.01650				605377_[DMPK_Myotonic_dystrophy_1,160900]
chr19	50338233	50365372	3	13	6	  27.139	0.115	MED25,PNKP	0.02310				610197_[MED25_Charcot-Marie-Tooth_disease,type_2B2,605589/Basel-Vanagait-Smirin-Yosef_syndrome,616449],605610_[PNKP_Microcephaly,seizures,and_developmental_delay,613402/Ataxia-oculomotor_apraxia_4,616267]
chr19	50430941	50432998	3	5	2	   2.057	0.159	IL4I1,NUP62,ATF5	0.00527				605815_[NUP62_Striatonigral_degeneration,infantile,271930]
chr19	50826222	50827349	3	5	1	   1.127	0.108	KCNC3	0.00253				176264_[KCNC3_Spinocerebellar_ataxia_13,605259]
chr19	54694109	54694311	4	5	1	   0.202	0.204	TSEN34	0.00402				608754_[TSEN34_Pontocerebellar_hypoplasia_type_2C,612390]
chr20	3208895	3209363	3	3	2	   0.468	0.191	SLC4A11	0.05409				610206_[SLC4A11_Corneal_endothelial_dystrophy,autosomal_recessive,217700/Corneal_endothelial_dystrophy_and_perceptive_deafness,217400/Corneal_dystrophy,Fuchs_endothelial,4,613268]
chr20	3209982	3210432	3	4	2	   0.450	0.134	SLC4A11	0.01779				610206_[SLC4A11_Corneal_endothelial_dystrophy,autosomal_recessive,217700/Corneal_endothelial_dystrophy_and_perceptive_deafness,217400/Corneal_dystrophy,Fuchs_endothelial,4,613268]
chr20	10629187	10629380	1	4	1	   0.193	0.089	JAG1	0.00143			JAG1	601920_[JAG1_Alagille_syndrome_1,118450/Tetralogy_of_Fallot,187500/Deafness,congenital_heart_defects,and_posterior_embryotoxon,617992]
chr20	43252833	43254335	1	4	2	   1.502	0.038	ADA,PKIG	0.00462				608958_[ADA_Severe_combined_immunodeficiency_due_to_ADA_deficiency,102700/Adenosine_deaminase_deficiency,partial,102700]
chr20	47632807	47632962	3	3	1	   0.155	0.045	ARFGEF2	0.00667				605371_[ARFGEF2_Periventricular_heterotopia_with_microcephaly,608097]
chr20	57478717	57478856	3	5	1	   0.139	0.083	GNAS	0.00290			GNAS	139320_[GNAS_Pseudohypoparathyroidism_Ia,103580/McCune-Albright_syndrome,somatic,mosaic_174800/Pseudohypoparathyroidism_Ic,612462/Osseous_heteroplasia,progressive,166350/Pseudohypoparathyroidism_Ib,603233/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudopseudohypoparathyroidism,612463/ACTH-independent_macronodular_adrenal_hyperplasia,219080]
chr20	57485379	57485466	1	4	1	   0.087	0.121	GNAS	0.00540			GNAS	139320_[GNAS_Pseudohypoparathyroidism_Ia,103580/McCune-Albright_syndrome,somatic,mosaic_174800/Pseudohypoparathyroidism_Ic,612462/Osseous_heteroplasia,progressive,166350/Pseudohypoparathyroidism_Ib,603233/Pituitary_adenoma_3,multiple_types,somatic,617686/Pseudopseudohypoparathyroidism,612463/ACTH-independent_macronodular_adrenal_hyperplasia,219080]
chr20	61980995	61991061	3	7	3	  10.066	0.223	CHRNA4	0.00959	yes		CHRNA4	118504_[CHRNA4_Epilepsy,nocturnal_frontal_lobe,1,600513/Nicotine_addiction,susceptibility_to,188890]
chr20	62070941	62073894	3	6	2	   2.953	0.127	KCNQ2	0.00281			KCNQ2	602235_[KCNQ2_Seizures,benign_neonatal,1,121200/Myokymia,121200/Epileptic_encephalopathy,early_infantile,7,613720]
chr20	62076581	62078200	3	6	2	   1.619	0.166	KCNQ2	0.00402			KCNQ2	602235_[KCNQ2_Seizures,benign_neonatal,1,121200/Myokymia,121200/Epileptic_encephalopathy,early_infantile,7,613720]
chr21	38852930	38853138	3	7	1	   0.208	0.115	DYRK1A	0.00045			DYRK1A	600855_[DYRK1A_Mental_retardation,autosomal_dominant_7,614104]
chr21	44485303	44485815	1	8	3	   0.512	0.070	CBS	0.00030				613381_[CBS_Homocystinuria,B6-responsive_and_nonresponsive_types,236200/Thrombosis,hyperhomocysteinemic,236200]
chr21	46305858	46306827	3	5	2	   0.969	0.089	ITGB2	0.02112				600065_[ITGB2_Leukocyte_adhesion_deficiency,116920]
chr21	46875414	46876100	3	10	1	   0.686	0.102	COL18A1	0.00011				120328_[COL18A1_Knobloch_syndrome,type_1,267750]
chr21	47404173	47406996	3	4	2	   2.823	0.083	COL6A1	0.01541			COL6A1	120220_[COL6A1_Bethlem_myopathy_1,158810/Ullrich_congenital_muscular_dystrophy_1,254090]
chr21	47773008	47773992	3	4	2	   0.984	0.159	PCNT	0.02894				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47775357	47775551	1	3	1	   0.194	0.089	PCNT	0.00634				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr21	47809104	47810757	3	4	2	   1.653	0.064	PCNT	0.00670				605925_[PCNT_Microcephalic_osteodysplastic_primordial_dwarfism,type_II,210720]
chr22	24175749	24891485	3	5	2	 715.736	0.102	SMARCB1,UPB1	0.01025	yes	yes	SMARCB1	601607_[SMARCB1_Rhabdoid_tumors,somatic,609322/Rhabdoid_tumor_predisposition_syndrome_1,609322/Coffin-Siris_syndrome_3,614608/Schwannomatosis-1,susceptibility_to,162091],153620_[MIF_Rheumatoid_arthritis,systemic_juvenile,susceptibility_to,604302],614140_[SPECC1L_Facial_clefting,oblique,1,600251/Opitz_GBBB_syndrome,type_II,145410/Hypertelorism,Teebi_type,145420],606673_[UPB1_Beta-ureidopropionase_deficiency,613161]
chr22	24916345	24919751	1	6	2	   3.406	0.102	UPB1	0.00805				606673_[UPB1_Beta-ureidopropionase_deficiency,613161]
chr22	33673036	33673251	3	12	1	   0.215	0.089	LARGE1	0.00002			LARGE1	603590_[LARGE1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,6,613154/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,6,608840]
chr22	33700205	33712244	3	6	2	  12.039	0.102	LARGE1	0.00253			LARGE1	603590_[LARGE1_Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies),type_A,6,613154/Muscular_dystrophy-dystroglycanopathy_(congenital_with_mental_retardation),type_B,6,608840]
chr22	42463759	42463950	3	4	1	   0.191	0.064	NAGA	0.00466				104170_[NAGA_Schindler_disease,type_I,609241/Kanzaki_disease,609242/Schindler_disease,type_III,609241]
chr22	43023300	43023405	1	3	1	   0.105	0.064	CYB5R3	0.00862			CYB5R3	613213_[CYB5R3_Methemoglobinemia,type_I,250800/Methemoglobinemia,type_II,250800]
chr22	43032711	43032862	3	3	1	   0.151	0.089	CYB5R3	0.00863			CYB5R3	613213_[CYB5R3_Methemoglobinemia,type_I,250800/Methemoglobinemia,type_II,250800]
chr22	46136239	46136428	3	4	1	   0.189	0.057	ATXN10	0.00562				611150_[ATXN10_Spinocerebellar_ataxia_10,603516]
chr22	46742309	46746370	1	5	2	   4.061	0.089	TRMU	0.01082				610230_[TRMU_Deafness,mitochondrial,modifier_of,580000/Liver_failure,transient_infantile,613070]
chr22	50301359	50301602	3	3	1	   0.243	0.083	ALG12	0.00612				607144_[ALG12_Congenital_disorder_of_glycosylation,type_Ig,607143]
chr22	50311901	50312116	5	4	1	   0.215	0.357	ALG12	0.06142				607144_[ALG12_Congenital_disorder_of_glycosylation,type_Ig,607143]
